{"study_id": 12258, "supplement_id": 1065, "safety_score": "70", "efficacy_score": 20, "quality_score": 65, "study_goal": "The researchers aimed to determine whether seven days of oral D-ribose supplementation would improve exercise tolerance in patients with McArdle's disease.", "results_summary": "The study found no significant difference in peak oxygen consumption or leg fatigue between D-ribose and placebo. Patients disliked taking D-ribose, and it did not appear beneficial for McArdle's disease.", "population_specificity": "5 patients with McArdle's disease", "effective_dosage": "60 g daily", "study_duration": "7 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:41.568592+00:00"}
{"study_id": 12259, "supplement_id": 1065, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine the effects of oral and intravenous D-Ribose administration on serum ribose, glucose, insulin, and c-peptide levels in healthy subjects.", "results_summary": "D-Ribose administration increased serum ribose levels dose-dependently and reduced serum glucose levels, with oral administration also increasing serum insulin concentrations. Intravenous administration did not significantly alter insulin or c-peptide levels.", "population_specificity": "Nine healthy subjects", "effective_dosage": "83.3 to 222.2 mg/kg per hour (oral and/or intravenous)", "study_duration": "At least four hours", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:43.559496+00:00"}
{"study_id": 64702, "supplement_id": 1065, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to review novel anti-TB medicines and treatment regimens under clinical evaluation, including those targeting cell wall inhibitors like decaprenylphosphoryl-\u03b2-d-ribose 2'-epimerase.", "results_summary": "The abstract does not provide specific findings on D-Ribose's effects, focusing instead on broader anti-TB drug development and clinical trial innovations.", "population_specificity": "Not specified (general focus on TB treatment).", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:43.821690+00:00"}
{"study_id": 64703, "supplement_id": 1065, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were attempting to identify new anti-tuberculosis treatments and novel therapeutic targets, focusing on nitroaromatic compounds.", "results_summary": "The abstract does not provide specific findings related to D-Ribose.", "population_specificity": "Not specified (abstract focuses on tuberculosis and drug-resistant strains).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:44.341436+00:00"}
{"study_id": 64704, "supplement_id": 1065, "safety_score": "70", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to review D-Ribose's digestion, absorption, metabolic pathways, cellular effects, and its potential link to diabetes mellitus.", "results_summary": "D-Ribose enhances ATP production and nucleotide synthesis, benefiting cardiac function and post-exercise fatigue, but may be linked to type 2 diabetes and apoptosis in certain cell lines.", "population_specificity": "Heart failure patients and individuals with post-exercise fatigue; potential implications for type 2 diabetes patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:46.330091+00:00"}
{"study_id": 64706, "supplement_id": 1065, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the synthesis, structure-activity relationship (SAR), and role of 1,3,4-oxadiazole derivatives as thymidine phosphorylase (TP) inhibitors for potential chemotherapeutic effects.", "results_summary": "The abstract highlights TP's role in cancer progression and its association with angiogenic factors, identifying it as a target for anticancer drug development. It emphasizes the significance of nitrogen-containing heterocycles, particularly 1,3,4-oxadiazole derivatives, as potential TP inhibitors.", "population_specificity": "Not specified (focus on TP in human cancers like breast and colorectal malignancies).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:48.738461+00:00"}
{"study_id": 64709, "supplement_id": 1065, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers reviewed the research progress of synthetic thymidine phosphorylase (TP) inhibitors, including their inhibitory activity, cytotoxicity, and potential applications in cancer treatment.", "results_summary": "The abstract highlights that TP inhibitors, including pyrimidine derivatives, show promise in inhibiting tumor growth and metastasis, but further research is needed on their biological activities, inhibitory mechanisms, and clinical applications.", "population_specificity": "Not specified (focus on synthetic TP inhibitors in general, not a specific human or animal population).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:50.113013+00:00"}
{"study_id": 64705, "supplement_id": 1065, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the safety, efficacy, and appropriate dosing of a 4-month regimen of QBS (an inhibitor involving D-Ribose metabolism) in combination with delamanid and bedaquiline for treating drug-susceptible pulmonary TB, compared to standard 6-month treatment.", "results_summary": "The abstract does not provide specific results regarding D-Ribose's effects, as the study focuses on QBS's role in a combination regimen for TB treatment. The trial is designed to assess culture conversion rates and safety endpoints, but outcomes are not yet reported.", "population_specificity": "Participants aged 18-65 with newly diagnosed pulmonary drug-sensitive TB, including up to 15% with HIV coinfection, from ~8 sites in South Africa.", "effective_dosage": "Not specified for D-Ribose (study evaluates QBS dosing in combination therapy).", "study_duration": "4-month treatment period, with follow-up until 12 months post-randomization.", "interactions": "None mentioned (study focuses on QBS interactions with delamanid and bedaquiline).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:51.525755+00:00"}
{"study_id": 64713, "supplement_id": 1065, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review patents and patent applications related to DprE1 inhibitors, including D-Ribose derivatives, for treating tuberculosis (TB).", "results_summary": "The abstract highlights DprE1 as a promising target for anti-TB drugs due to its selectivity for Mycobacterium tuberculosis (Mtb) and potential minimal side effects in humans. Four DprE1 inhibitor molecules are currently in clinical trials.", "population_specificity": "Not specified (focus on patent review and preclinical/clinical development).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:51.959158+00:00"}
{"study_id": 64715, "supplement_id": 1065, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the diagnostic and restorative potential of purines, including ATP and adenosine, in conditions like stroke.", "results_summary": "The abstract discusses the broad biological functions of purines, their role in energy regulation, and their potential for diagnosing and restoring ATP levels during metabolic stress, but does not specifically mention D-Ribose.", "population_specificity": "Not specified (general discussion of purines in cellular and systems-level physiology).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:52.238243+00:00"}
{"study_id": 64707, "supplement_id": 1065, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the safety, tolerability, and early bactericidal activity of OPC-167832 (an inhibitor of decaprenylphosphoryl-\u03b2-d-ribose 2'-oxidase) in healthy participants and those with drug-susceptible pulmonary tuberculosis.", "results_summary": "OPC-167832 was well tolerated with mostly mild, self-limiting adverse events (e.g., headache, pruritus) and no significant safety concerns. Plasma exposure increased in a less than dose-proportional manner, and the compound showed early bactericidal activity in TB patients.", "population_specificity": "Healthy participants and individuals with drug-susceptible pulmonary tuberculosis.", "effective_dosage": "Single ascending doses (10\u2013480 mg) in healthy participants; multiple ascending doses (3\u201390 mg QD) in TB patients.", "study_duration": "14 days (MAD study).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:52.756974+00:00"}
{"study_id": 64712, "supplement_id": 1065, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to investigate the multi-omics characteristics (gut microbiota, serum metabolome, and proteome) in patients with ulcerative colitis (UC) and depression/anxiety, and explore potential metabolite effects on depressive-like behavior in mice with colitis.", "results_summary": "The study found that 58% of active UC patients had depression and 50% had anxiety, with lower microbial richness and diversity in these groups. Multi-omics correlations were analyzed, and candidate metabolites were tested for effects on depressive-like behavior in mice, but D-Ribose-specific results were not mentioned.", "population_specificity": "240 Chinese participants (129 active UC patients, 49 non-UC depression/anxiety patients, 62 healthy controls).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:53.063355+00:00"}
{"study_id": 64716, "supplement_id": 1065, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to review the enzymatic properties, structural features, catalytic mechanisms, and applications of ribose-5-phosphate isomerase (Rpi) in rare sugar production and as a potential drug target.", "results_summary": "The study summarized the fundamental properties of various Rpis, differences in crystal structure and catalytic mechanisms between RpiA and RpiB, and highlighted Rpi's applications in rare sugar production and potential as a drug target for trypanosomatid-caused diseases.", "population_specificity": "Not specified (focus on enzymatic and structural properties, not human trials).", "effective_dosage": "Not available", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:56.079523+00:00"}
{"study_id": 64717, "supplement_id": 1065, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 50, "study_goal": "The researchers aimed to explore the role of D-ribose in Alzheimer's disease progression, focusing on its glycation ability and formation of advanced glycation end products (AGEs).", "results_summary": "The study suggests D-ribose has high glycation potential, rapidly producing AGEs, which may contribute to cognitive impairments and Alzheimer's disease risk, particularly in diabetic patients. However, no direct therapeutic or diagnostic outcomes were demonstrated.", "population_specificity": "Aging population and diabetic patients at risk of neurodegenerative diseases like Alzheimer's.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:57.323574+00:00"}
{"study_id": 64719, "supplement_id": 1065, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the anti-glycating potential of various statins, alone or in combination with ezetimibe and tocotrienol, against D-Ribose-mediated glycation of BSA and LDL.", "results_summary": "The study found that atorvastatin, tocotrienol, rosuvastatin, ezetimibe, and their combinations significantly inhibited AGEs formation by modulating protein structure and glycation markers in Gly-BSA and Gly-LDL.", "population_specificity": "Not specified (in vitro study using BSA and LDL).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:58.695646+00:00"}
{"study_id": 64721, "supplement_id": 1065, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to identify and characterize ribose 5-phosphate isomerase (R5PI) as a potential molecular target for developing new drugs against Leishmania parasites.", "results_summary": "The study identified R5PI as a promising target, modeled the 3D structures of RpiB (parasitic form) and RpiA (human form), and proposed distinct reaction mechanisms for each enzyme. The findings could guide future drug development to selectively inhibit the parasitic enzyme without affecting the human analog.", "population_specificity": "In silico analysis (no human or animal subjects).", "effective_dosage": "Not available", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:00.755299+00:00"}
{"study_id": 64722, "supplement_id": 1065, "safety_score": "40", "efficacy_score": 20, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the effectiveness and safety of D-Ribose in improving exercise performance and quality of life in patients with McArdle disease.", "results_summary": "The study found no benefit with D-Ribose in improving exercise performance or quality of life. Adverse effects included diarrhoea and symptoms suggestive of hypoglycaemia, such as light-headedness and hunger.", "population_specificity": "Patients with McArdle disease (Glycogen Storage Disease type V).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:00.757402+00:00"}
{"study_id": 64720, "supplement_id": 1065, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore the potential of DprE1 (Decaprenylphosphoryl-d-ribose 2'-epimerase) as a drug target for treating tuberculosis, given its role in the epimerization process critical for mycobacterial survival.", "results_summary": "The abstract highlights DprE1 as a vulnerable target for antitubercular drug discovery due to its role in converting decaprenylphosphoryl-d-ribose to decaprenylphosphoryl-d-arabinose, a process essential for mycobacterial cell wall synthesis. Compounds like benzothiazinones show promising activity against Mycobacterium tuberculosis, but challenges like drug resistance remain.", "population_specificity": "Not specified (focused on Mycobacterium tuberculosis and Mycobacterium leprae).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:01.990664+00:00"}
{"study_id": 64724, "supplement_id": 1065, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to explore whether D-Ribose, among other nutrients, could alleviate mitochondrial cardiotoxic effects induced by various agents.", "results_summary": "The study suggests that D-Ribose may help mitigate mitochondrial cardiotoxic effects, alongside other antioxidants and nutrients, but does not provide specific data on its efficacy. Recovery from cardiotoxicity often occurs after discontinuation of the offending agent, with nutrients like D-Ribose potentially aiding the process.", "population_specificity": "Humans with mitochondrial dysfunction-induced cardiotoxicity (general mention, no specific subgroup detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:01.998436+00:00"}
{"study_id": 64723, "supplement_id": 1065, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the antiplatelet aggregation activity of monosaccharides, including D-Ribose, extracted from sorghum vinegar and analyze its mechanism.", "results_summary": "D-Ribose, as part of the alditol and monosaccharide extract (AME), showed significant antiplatelet activity by inhibiting platelet aggregation induced by arachidonic acid, collagen, ADP, and thrombin, likely through the AA metabolism pathway. Computational docking indicated D-Ribose could directly dock into the active site of COX1, suggesting a potential mechanism for its effects.", "population_specificity": "Healthy volunteer donors (in vitro study).", "effective_dosage": "0.10, 0.25, and 0.50 mg/mL (in vitro concentrations).", "study_duration": "Not specified (in vitro study).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:04.173992+00:00"}
{"study_id": 64726, "supplement_id": 1065, "safety_score": "Not Assessed", "efficacy_score": 10, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of D-Ribose in improving exercise performance and quality of life in patients with McArdle disease.", "results_summary": "The study found no benefit with D-Ribose in improving exercise performance or other outcomes in McArdle disease patients. The abstract does not report any positive effects or clinical benefits from D-Ribose supplementation.", "population_specificity": "Patients with McArdle disease (Glycogen Storage Disease type V).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:05.349645+00:00"}
{"study_id": 64725, "supplement_id": 1065, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 50, "study_goal": "The researchers aimed to evaluate the role of apoptosis in Alagille syndrome (AGS) patients carrying a truncating mutation in JAG1, specifically examining the effects of 2-deoxy-d-ribose (dRib) on peripheral blood lymphocytes (PBLs).", "results_summary": "PBLs from AGS patients showed significantly higher apoptosis than controls under standard conditions and after dRib treatment, but caspase-8 activation was lacking, suggesting JAG1 mutations may impair apoptosis regulation.", "population_specificity": "Two AGS patients with truncating mutations in exon 7 of JAG1.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:05.503207+00:00"}
{"study_id": 64728, "supplement_id": 1065, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate D-Ribose's potential to replenish cellular energy levels and improve function in myocardial ischemia and congestive heart failure.", "results_summary": "D-Ribose demonstrated significant enhancement of deficient cellular energy levels and improved depressed function in animal studies and clinical trials involving patients with ischemic cardiovascular disease and congestive heart failure.", "population_specificity": "Patients with ischemic cardiovascular disease and congestive heart failure, as well as pre-clinical animal models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:06.687830+00:00"}
{"study_id": 197094, "supplement_id": 1065, "safety_score": "30", "efficacy_score": null, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the potential risks and negative effects of D-Ribose supplementation, particularly its glycation capacity and cytotoxic effects.", "results_summary": "The study highlights significant concerns regarding D-Ribose, including its potential to force ribose-5-phosphate into the pentose phosphate pathway and its notable glycation capacity, which may lead to cytotoxic effects. The abstract suggests that the literature supporting D-Ribose as a supplement underestimates these risks.", "population_specificity": "Not specified (general discussion, not a clinical study)", "effective_dosage": "Not provided", "study_duration": "Not provided", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:09.490576+00:00"}
{"study_id": 197096, "supplement_id": 1065, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of dietary modifications, including D-Ribose supplementation, in alleviating chronic fatigue syndrome symptoms.", "results_summary": "The study found positive outcomes for D-Ribose supplementation in humans regarding chronic fatigue syndrome symptom alleviation, though the overall evidence was narrow and inconsistent across studies.", "population_specificity": "Humans with chronic fatigue syndrome.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:10.494557+00:00"}
{"study_id": 197095, "supplement_id": 1065, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether D-ribose supplementation reduces delayed onset muscle soreness (DOMS) and improves recovery after plyometric exercise.", "results_summary": "D-ribose significantly reduced muscle soreness and markers of muscle damage (e.g., creatine kinase, LDH, myoglobin, MDA) compared to placebo, but did not affect muscle strength or oxidative stress markers.", "population_specificity": "21 untrained male college students", "effective_dosage": "15 g doses ingested 1-h before, 1-h, 12-h, 24-h, and 36-h after exercise", "study_duration": "Single session with measurements up to 48-h post-exercise", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:11.227677+00:00"}
{"study_id": 197097, "supplement_id": 1065, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of a carbohydrate-, protein-, and ribose-containing repletion drink versus carbohydrates alone on aerobic capacity, body composition, and performance during an 8-week aerobic training program.", "results_summary": "The study found that the test drink (containing D-Ribose) did not enhance body weight, aerobic capacity, or time to exhaustion more than carbohydrates alone but did improve body composition (reducing percent body fat and increasing fat-free mass) within the first 3-6 weeks of supplementation.", "population_specificity": "32 men (mean age 23 \u00b1 3 years) undergoing aerobic training.", "effective_dosage": "2.2 g D-Ribose per serving, ingested immediately after training.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:11.698671+00:00"}
{"study_id": 11560, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine the role of D-serine in early Alzheimer's disease (AD) pathogenesis and whether its modulation could prevent or reduce NMDAR-related synaptic and cognitive impairments in an AD mouse model.", "results_summary": "The study found that D-serine levels transiently increased with early A\u03b2 accumulation, correlating with NMDAR synaptic impairments and later cognitive deficits in 5xFAD mice. Genetic deletion of D-serine synthesis prevented or reduced these impairments, suggesting its role in early AD pathology.", "population_specificity": "5xFAD mice (an Alzheimer's disease-related model with elevated A\u03b2 levels)", "effective_dosage": "Not specified", "study_duration": "Observations from 1.5 to 12 months of age", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:14.196403+00:00"}
{"study_id": 11564, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of D-serine and DAO in first-episode schizophrenia spectrum disorders by comparing their levels before and after six months of treatment.", "results_summary": "Patients had significantly lower D-serine and DAO levels before treatment compared to healthy controls, but levels increased after six months of treatment. DAO levels correlated with antipsychotic dosage and symptom severity, but no correlation was found with cognitive function.", "population_specificity": "89 patients with first-episode schizophrenia spectrum disorders and 81 healthy controls.", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:14.309098+00:00"}
{"study_id": 11561, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine how D-serine binding to GluD1 affects its interaction with Cbln1 and its subsequent impact on synaptic function and behavior.", "results_summary": "D-serine inhibited the interaction between Cbln1 and GluD1 in vitro and partially blocked the synaptogenic effects of rCbln1 in ex vivo and behavioral experiments, suggesting a role in synaptic plasticity and nociception.", "population_specificity": "Central amygdala (CeA) slices and behavioral models (inflammatory pain).", "effective_dosage": "IC50 value of ~300 \u00b5M (in vitro).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:15.620418+00:00"}
{"study_id": 11566, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine if serum levels of D-serine and other NMDAR-related amino acids differ between Parkinson's disease (PD) patients and healthy controls, and if these levels correlate with clinical-demographic features and levodopa equivalent daily dose (LEDD).", "results_summary": "The study found no initial differences in serum D-serine levels between PD patients and healthy controls, but after adjusting for LEDD, D-serine levels were significantly higher (\u224838%) in PD patients. D-serine and D-/Total serine ratio positively correlated with age and age at onset in PD patients, while higher LEDD correlated with lower D-serine levels.", "population_specificity": "83 Parkinson's disease patients and 41 healthy controls.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Levodopa equivalent daily dose (LEDD) was noted to correlate with lower D-serine levels.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:17.581128+00:00"}
{"study_id": 11569, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "To investigate whether serum d-serine levels can predict hearing impairment in uremic patients.", "results_summary": "Higher d-serine levels and older age were associated with increased risk of hearing impairment, while l-serine acted as a protective factor. The ROC curve analysis indicated d-serine had significant predictive value for hearing impairment in uremic patients.", "population_specificity": "Uremic patients (30 with hearing impairment and 30 with normal hearing).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:19.012102+00:00"}
{"study_id": 11567, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether co-administration of D-serine and Tat-GluA23y could alleviate memory impairment in a sporadic Alzheimer's model of ovariectomized rats.", "results_summary": "Co-administration of D-serine and GluA23y significantly improved spatial memory acquisition and retrieval in ovariectomized rats with Alzheimer's-like symptoms, with D-serine showing greater improvement than GluA23y alone. The effect was linked to increased phosphorylated CREB protein levels in the hippocampus.", "population_specificity": "Female Wistar rats (ovariectomized, Alzheimer's model induced by streptozotocin)", "effective_dosage": "Not specified", "study_duration": "Treatment administered until day 51", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:19.255702+00:00"}
{"study_id": 11568, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to synthesize new information about NMDARs and D-Serine's role in synaptic plasticity and its potential therapeutic effects in temporal lobe epilepsy (TLE).", "results_summary": "The abstract suggests D-Serine may act as an inverse co-agonist for t-NMDARs and highlights its potential role in linking neurodegeneration with neuroinflammation, offering therapeutic promise for TLE.", "population_specificity": "Focused on implications for neurodegenerative diseases, particularly temporal lobe epilepsy (TLE).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:19.323367+00:00"}
{"study_id": 11570, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effectiveness of D-Serine combined with auditory cognitive remediation (AudRem) in improving NMDA receptor-dependent auditory plasticity in patients with schizophrenia or schizoaffective disorder.", "results_summary": "D-Serine at 80 and 100 mg/kg significantly improved auditory plasticity, with sustained effects after a single treatment. The 100 mg/kg dose also demonstrated significant target engagement via mismatch negativity, while the 120 mg/kg dose and placebo showed nonsignificant changes.", "population_specificity": "Patients with schizophrenia or schizoaffective disorder (n=45).", "effective_dosage": "80, 100, or 120 mg/kg once weekly.", "study_duration": "3 once-weekly AudRem visits.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:23.022537+00:00"}
{"study_id": 11571, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether D-Serine could inhibit the expression of the pks island in colibactin-producing E. coli strains and reduce cytopathic effects on host cells.", "results_summary": "D-Serine strongly repressed clbB transcription (3.8-fold reduction) and reduced DNA damage (2.75-fold decrease in \u03b3-H2AX) and cellular senescence in infected HeLa cells. It was the most effective among tested D-amino acids in inhibiting colibactin-associated cytopathy.", "population_specificity": "HeLa cells infected with pks+ E. coli strains (prototypic and clinically-associated).", "effective_dosage": "Not specified", "study_duration": "Effects observed up to 72 hours post-infection.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:23.788719+00:00"}
{"study_id": 11573, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to investigate the correlation between D-serine levels and hearing impairment in maintenance hemodialysis patients with end-stage renal disease.", "results_summary": "The study found that D-serine levels were significantly higher in hemodialysis patients with hearing impairment compared to those with normal hearing and controls, and elevated D-serine was identified as a risk factor for hearing impairment. A moderate positive correlation was observed between D-serine and FGF23 levels.", "population_specificity": "Maintenance hemodialysis patients with end-stage renal disease, including those with and without hearing impairment, and healthy controls.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:24.564704+00:00"}
{"study_id": 11572, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether downregulation of D-serine-mediated NMDA receptor signaling, combined with inhibition of neurogenesis, could weaken remote contextual fear memory through disruption of retrieval-induced reconsolidation.", "results_summary": "The study found that simultaneous reduction of D-serine signaling and dampening of neurogenesis led to a progressive decrease in freezing behavior after each retrieval, ultimately attenuating remote contextual fear memory. Pharmacological blockade of D-serine signaling and neurogenesis post-conditioning similarly suppressed remote fear memory.", "population_specificity": "Animal model (contextual fear conditioning paradigm, not specified if rodents or other species).", "effective_dosage": "Not specified (genetic reduction and pharmacological approaches used, but exact dosages not detailed).", "study_duration": "Follow-up until day 28 post-conditioning (intervention duration not explicitly stated).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:25.127349+00:00"}
{"study_id": 11575, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether sAPP\u03b1 treatment could improve NMDAR activation and cognitive aging by targeting D-serine-dependent deregulation.", "results_summary": "The study found that sAPP\u03b1 significantly increased NMDAR activation in aged mice and rescued age-related deficits in long-term potentiation, with effects dependent on D-serine availability.", "population_specificity": "Young and aged mice (hippocampal slices)", "effective_dosage": "0.1 nM and 1 nM sAPP\u03b1 (bath application)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:27.434683+00:00"}
{"study_id": 11574, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether D-serine, alone or in combination with atomoxetine, could improve attention by reducing attentional lapses in a rat model.", "results_summary": "D-serine reduced attentional lapses (measured by IT devmode) at 300 mg/kg, and a combination of low-dose D-serine (125 mg/kg) and atomoxetine (0.3 mg/kg) showed greater effects than either drug alone without additional movement speed impairment.", "population_specificity": "Rats performing a two-choice visuospatial discrimination task.", "effective_dosage": "300 mg/kg (high dose), 125 mg/kg (low dose, combined with atomoxetine).", "study_duration": "Not specified.", "interactions": "Combination with atomoxetine (a norepinephrine reuptake inhibitor) was tested.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:27.577616+00:00"}
{"study_id": 11577, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the potential of D-Serine as a disease-modifying therapy for treatment-resistant schizophrenia (TRS) by examining its biological role and effects on NMDAR function.", "results_summary": "The study suggests that D-Serine may modulate NMDAR activity and dopaminergic neuron function, potentially offering therapeutic benefits for TRS, particularly in addressing negative symptoms and cognitive deficits. However, the abstract does not provide specific clinical trial results or statistical outcomes.", "population_specificity": "Patients with treatment-resistant schizophrenia (TRS).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:28.325267+00:00"}
{"study_id": 11580, "supplement_id": 1066, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to determine if D-serine supplementation could reverse age-related brain alterations, including cognitive flexibility, neuronal morphology, and functional connectivity in rats.", "results_summary": "D-serine supplementation reversed age-related cognitive decline, increased frontal dendritic spine density, and partially restored large-scale functional connectivity without nephrotoxicity; it also restored renal epithelial cell thickness affected by aging.", "population_specificity": "Aged rats", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:32.163549+00:00"}
{"study_id": 11579, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effects of reduced mitochondrial antioxidant response in astrocytes on cognitive function, including the role of D-Serine, in aging mice.", "results_summary": "The study found that reduced astrocyte SOD2 levels led to decreased D-Serine levels in mice, impairing hippocampal-dependent spatial working memory and cognitive flexibility in males, while females showed compensatory mechanisms.", "population_specificity": "C57BL/6J mice (male and female, aged 11-12 months at intervention, tested at 15 months).", "effective_dosage": "Not specified", "study_duration": "Intervention duration not specified; testing occurred at 15 months of age.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:32.951175+00:00"}
{"study_id": 11578, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of D-Serine (an NMDA receptor agonist) on spermatogonia differentiation in a 3D culture system using a decellularized testicular matrix hydrogel scaffold.", "results_summary": "D-Serine significantly increased spermatogonia proliferation and expression of pre-meiotic, meiotic, and post-meiotic genes in 3D culture, while MK801 (an antagonist) reduced these markers. The 3D + D-Serine group showed the most pronounced positive effects on spermatogenic differentiation.", "population_specificity": "Spermatogonia in a laboratory culture system (not human subjects).", "effective_dosage": "Not specified", "study_duration": "Up to eight weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:32.957558+00:00"}
{"study_id": 11581, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine if d-serine levels in blood and urine could serve as a biomarker to diagnose diabetic nephropathy (DN) and distinguish it from other kidney diseases.", "results_summary": "The study found that a d-serine blood level >2.34 \u03bcM combined with a urinary fractional excretion threshold of 47% effectively identified DN with high sensitivity (79%) and specificity (83%). The model outperformed clinical factors alone in predicting DN.", "population_specificity": "Patients with biopsy-proven DN, primary GN (minimal change disease and IgA nephropathy), and participants without kidney disease (total n=388).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:35.110842+00:00"}
{"study_id": 11584, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the role and mechanisms of D-serine in depressive behavior in the nucleus accumbens (NAc) using a chronic social defeat stress (CSDS) model.", "results_summary": "D-Serine exhibited antidepressant-like effects in mice, mediated by restraining the BDNF signaling pathway and regulating synaptic plasticity in the NAc. It was effective in both control and CSDS models, enhancing NMDAR-dependent long-term depression (LTD).", "population_specificity": "Mice (control and CSDS model)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:36.934226+00:00"}
{"study_id": 11583, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate dysfunctions in D-serine metabolism related to ADHD-like behaviors in an animal model (SHRSP/Ezo rats) and assess whether modulating D-serine levels could attenuate these behaviors.", "results_summary": "The study found that SHRSP/Ezo rats had lower D-serine levels due to altered enzyme activity (higher DAAO, lower SR). Inhibiting DAAO in the mPFC increased D-serine levels and reduced ADHD-like behaviors, while similar intervention in the hippocampus had no behavioral effect.", "population_specificity": "Juvenile stroke-prone spontaneously hypertensive rats (SHRSP/Ezo), an animal model of ADHD.", "effective_dosage": "Not specified (microinjection of DAAO inhibitor, exact dosage not detailed).", "study_duration": "Not specified (acute intervention, duration not detailed).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:38.872598+00:00"}
{"study_id": 11576, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the origin of brain D-serine in mice, particularly focusing on SR-independent sources.", "results_summary": "The study found that while loss of serine racemase (SR) significantly reduced D-serine in the cerebral cortex, a portion remained in both neonates and adults. Dietary and intestinal bacterial sources did not fully account for brain D-serine, suggesting an endogenous, SR-independent origin.", "population_specificity": "Mice (neonatal and adult)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:39.154501+00:00"}
{"study_id": 11586, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the role of NMDAR and D-serine in retinal field potentials of the outer retina and how these effects vary by sex.", "results_summary": "Reduced NMDAR function (due to D-serine deficiency) delayed the a-wave and reduced the b-wave in SR-/- mice, with more pronounced effects in males. Exogenous D-serine in WT mice caused similar changes, but these were not observed in females, suggesting sex-dependent effects.", "population_specificity": "Male and female SR-/- mice and their littermate WT controls.", "effective_dosage": "5 mM D-serine (topical delivery).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:42.005017+00:00"}
{"study_id": 11588, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the effects of D-serine in preventing and treating inflammatory bowel disease (IBD) using a murine model.", "results_summary": "D-serine reduced T-cell infiltration and colonic inflammation when administered before colitis induction and suppressed disease progression when given after induction. It also inhibited CD4 T cell proliferation and differentiation into Th1 and Th17 cells in vitro.", "population_specificity": "Rag2-/- mice with adoptively transferred na\u00efve CD4 T cells from wild-type mice.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:43.208222+00:00"}
{"study_id": 11587, "supplement_id": 1066, "safety_score": "20", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether silica-coated magnetic nanoparticles (MNPs@SiO2(RITC))-induced microglial activation leads to excitotoxicity in neurons via D-serine secretion.", "results_summary": "The study found that MNPs@SiO2(RITC)-activated microglia increased D-serine secretion, which caused excitotoxicity in cocultured neurons, reducing ATP levels and proteasome activity while increasing ubiquitinated protein accumulation. In vivo, MNPs@SiO2(RITC) and D-serine were associated with ubiquitin aggresomes in the brain.", "population_specificity": "BV2 murine microglial cells, primary rat microglia, primary cortical and dopaminergic neurons, and mouse brain tissue.", "effective_dosage": "10 \u00b5g/ml and 100 \u00b5g/ml MNPs@SiO2(RITC) for microglial treatment.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:43.693587+00:00"}
{"study_id": 11585, "supplement_id": 1066, "safety_score": "85", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to review the safety profile of D-Serine, particularly focusing on nephrotoxicity concerns in humans, and assess its potential as a treatment for psychiatric and neurological conditions.", "results_summary": "The study found that D-Serine-induced nephrotoxicity is highly common in rats at doses >500 mg/kg but has not been reported in other species, including humans. In human studies, only one case of transient renal abnormalities was reported, and D-Serine appears safe at currently tested doses, especially when combined with DAAO inhibitors.", "population_specificity": "Rats, mice, rabbits, and humans (primarily focusing on human safety data).", "effective_dosage": "Human studies tested up to 120 mg/kg, achieving a Cmax of ~500 nmol/mL.", "study_duration": "Not specified in the abstract.", "interactions": "DAAO inhibitors may be nephroprotective when combined with D-Serine.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:43.944988+00:00"}
{"study_id": 11589, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether D-Serine plays a role in dopamine-glutamate interactions in the prefrontal cortex and its impact on cognitive functions.", "results_summary": "The study found that D-Serine is essential for fine-tuning glutamatergic neurotransmission, neuronal excitability, and synaptic plasticity in the PFC, mediated by dopamine receptors D1 and D3. It also demonstrated that D-Serine is required for cognitive enhancement via D3 receptor blockade in novel object recognition memory tests.", "population_specificity": "Prefrontal cortex (PFC) neuronal activity in animal models (implied by electrophysiological and in vivo microdialysis methods).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:46.277825+00:00"}
{"study_id": 11582, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the physiological functions of D-Serine, particularly its role in kidney function and remodeling.", "results_summary": "The study found that D-Serine is dominantly distributed to the kidney, promotes kidney enlargement in mice, and activates tissue remodeling via an mTOR-related pathway. It also showed that D-Serine levels increase in blood after kidney donation in humans.", "population_specificity": "Human living kidney donors and mice (including unilateral nephrectomy models and genetically modified cells).", "effective_dosage": "\"Low dose\" (specific amount not provided)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:46.546143+00:00"}
{"study_id": 11590, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine whether D-serine serum levels and the D-serine/total serine ratio are linked to executive function impairment in schizophrenia patients.", "results_summary": "The study found that lower D-serine serum levels and D-serine/total serine ratios were significantly associated with worse executive function performance in schizophrenia patients, suggesting a potential role of D-serine in NMDA receptor dysfunction.", "population_specificity": "Schizophrenia patients (n = 50) undergoing treatment with first- and second-generation antipsychotics.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:46.835091+00:00"}
{"study_id": 11591, "supplement_id": 1066, "safety_score": "20", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether NMDAR hyperfunction contributes to D-Serine-induced renal injury and whether NMDAR blockade could mitigate this effect.", "results_summary": "D-Serine induced dose-dependent cytotoxicity in proximal tubule cells, mediated by NMDAR activation and oxidative stress, which was alleviated by NMDAR blockers. In rats, D-Serine caused renal injury, which was prevented by cotreatment with the NMDAR blocker MK-801.", "population_specificity": "Male Wistar rats and NMDAR-expressing LLC-PK1 cells (proximal tubule model).", "effective_dosage": "Not specified (dose-dependent in vitro, intraperitoneal administration in vivo).", "study_duration": "24 hours (peak effects), with persistent damage observed after 7 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:49.498068+00:00"}
{"study_id": 11592, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to investigate the expression patterns of D-serine and NMDA receptor 1 in the temporal lobes of patients with intractable epilepsy compared to controls.", "results_summary": "D-serine expression was significantly higher in neurons and glial cells of intractable epilepsy patients than in controls. NMDA receptor 1 expression was also significantly elevated in the epilepsy group, suggesting a potential role for the D-serine signaling pathway in epilepsy treatment.", "population_specificity": "20 patients with intractable epilepsy (11 males, 9 females) and 6 brain trauma controls.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:50.834413+00:00"}
{"study_id": 11593, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether D-Serine could inhibit MRSA and E. coli attachment and biofilm formation, and assess its therapeutic potential in vivo.", "results_summary": "D-Serine reduced MRSA and E. coli attachment and biofilm formation by downregulating related genes (AgrA, SarS, IcaA, DltD, SdrD) without affecting bacterial proliferation. It also decreased MRSA colonization in catheters and infection severity in a mouse model.", "population_specificity": "In vitro MRSA and E. coli cultures, and an in vivo mouse catheter-induced peritonitis model.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:52.449596+00:00"}
{"study_id": 11594, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether D-serine could alleviate learning and memory impairments caused by lead exposure in rats and explore its potential mechanism involving hippocampal NR2A expression.", "results_summary": "D-serine treatment improved learning and memory in lead-exposed rats, as evidenced by reduced escape latency in the Morris water maze and increased platform crossings. It also restored hippocampal NR2A expression levels, which were reduced by lead exposure, but did not affect NR2B expression.", "population_specificity": "Rat models with chronic lead exposure", "effective_dosage": "30 or 60 mg/kg, intraperitoneally, twice a day", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:52.508510+00:00"}
{"study_id": 11595, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether intracranial infusion of D-Serine could prevent neuron loss and epileptogenesis in a rat model of Temporal Lobe Epilepsy (TLE).", "results_summary": "Daily intracranial infusion of D-Serine prevented neuron loss in the CA1 region, mitigated neuroinflammation by downregulating astrocytes and microglia, and reduced epileptogenesis, with effects primarily observed in the CA1 subfield.", "population_specificity": "Rat pilocarpine model of Temporal Lobe Epilepsy (TLE).", "effective_dosage": "100 \u03bcM, daily intracranial infusion.", "study_duration": "Daily administration (specific duration not stated).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:53.076565+00:00"}
{"study_id": 11596, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether D-serine could mitigate neuronal loss and neuroinflammation in an animal model of temporal lobe epilepsy (TLE), thereby preventing epileptogenesis.", "results_summary": "Focal administration of D-serine attenuated neuronal loss in the medial entorhinal area (MEA), reduced astrocyte counts, altered their reactive status, and curtailed microglial proliferation/infiltration, preventing epileptogenesis in a TLE model. D-serine demonstrated potential as a therapeutic agent for refractory TLE due to its neuroprotective and anti-inflammatory properties.", "population_specificity": "Animal model of temporal lobe epilepsy (TLE)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:55.429569+00:00"}
{"study_id": 11598, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether D-serine could improve motor and cognitive impairment in A\u03b2-injected mice by inhibiting the JNK signaling pathway.", "results_summary": "D-serine treatment improved movement and memory abilities in A\u03b2-injected mice, accelerated A\u03b2 clearance, and reduced the expression of inflammatory and JNK-related markers (GFAP, TNF-\u03b1, NMDAR1, p-JNK, p-c-Jun, ATF2). DAAO and BE administration further validated these findings.", "population_specificity": "Kunming mice with A\u03b21-42-induced Alzheimer's-like pathology.", "effective_dosage": "Not specified (intraperitoneal injection for 10 days).", "study_duration": "10 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:56.427922+00:00"}
{"study_id": 11597, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether combining D-Serine with auditory neuroplasticity cognitive remediation (AudRem) enhances efficacy and produces sustained improvements in schizophrenia/schizoaffective disorder patients.", "results_summary": "Previous studies showed that D-Serine alone improves symptoms and mismatch negativity (MMN), while combining it with AudRem yielded the strongest results for plasticity outcomes (pitch thresholds, MMN, and auditory \u03b8). The ongoing study tests dose optimization (80/100/120 mg/kg) and sustained effects.", "population_specificity": "45 schizophrenia/schizoaffective disorder patients", "effective_dosage": "80, 100, and 120 mg/kg (three separate dose cohorts)", "study_duration": "Three placebo-controlled, double-blind sessions (R61 phase); sustained effects assessed over three years (R33 phase)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:56.916848+00:00"}
{"study_id": 11599, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of a novel, orally bioavailable \u03b2-lactamase inhibitor (ETX1317) in combination with cefpodoxime proxetil for treating multidrug-resistant Gram-negative bacterial infections.", "results_summary": "The study found that ETX1317 exhibits broad-spectrum activity against class A, C, and D serine \u03b2-lactamases, and its prodrug ETX0282 is orally bioavailable, making it a promising candidate for oral therapy against resistant infections.", "population_specificity": "Multidrug-resistant and carbapenem-resistant Enterobacterales infections.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:38:58.875031+00:00"}
{"study_id": 11601, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the potential of D-Serine as a biomarker for early detection and prognostic prediction of kidney diseases.", "results_summary": "The study suggests that D-Serine's intra-body dynamics, measured through blood levels and urinary excretion, can provide a comprehensive assessment of kidney function and disease activity, potentially improving early detection and treatment decisions.", "population_specificity": "Patients with kidney diseases (specific population not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:00.005161+00:00"}
{"study_id": 11600, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether L-Theanine inhibits D-Serine uptake in SH-SY5Y neuroblastoma cells and assess the effect of S-ketamine on D-Serine transport.", "results_summary": "L-Theanine competitively inhibited D-Serine uptake with an IC50 of 9.68 mM, while S-ketamine showed no acute inhibition but increased intracellular D-Serine content after long-term treatment.", "population_specificity": "SH-SY5Y neuroblastoma cells (in vitro model).", "effective_dosage": "L-Theanine (various concentrations), S-ketamine (50 \u03bcM).", "study_duration": "Acute and long-term (72 hours) treatments.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:00.561647+00:00"}
{"study_id": 11602, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of repetitive transcranial magnetic stimulation (rTMS) on NMDAR-related amino acids, including D-Serine, in post-stroke patients.", "results_summary": "D-Serine decreased in the rehabilitation with rTMS group but increased in the rehabilitation without rTMS group, suggesting rTMS modulates NMDAR-related amino acids. L-Serine showed opposite trends.", "population_specificity": "Post-stroke patients with upper limb hemiparesis, including depressed (BDI \u226510) and non-depressed subgroups.", "effective_dosage": "Not specified", "study_duration": "14 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:01.404430+00:00"}
{"study_id": 11603, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the role of renal tubules in the derangement of serine enantiomers, particularly D-serine, using a mouse model of cisplatin-induced tubular injury.", "results_summary": "Cisplatin treatment increased the serum D-/L-serine ratio, correlating with kidney dysfunction markers (creatinine, BUN). The study identified Asc-1 transporter induction as a mechanism for D-serine accumulation, with no association to D-amino acid oxidase activity.", "population_specificity": "Mice with cisplatin-induced tubular injury (proximal tubules and collecting ducts).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:01.618144+00:00"}
{"study_id": 11604, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to investigate the role of D-serine as a potential biomarker in acute kidney injury (AKI) and rapidly progressive glomerulonephritis (RPGN), and its correlation with treatment efficacy.", "results_summary": "The study found that plasma D-serine levels were extremely high during the fulminant period of RPGN and normalized with intensive treatment, reflecting recovery of glomerular filtration rate (GFR). Urinary fractional excretion of D-serine transiently increased before normalization, suggesting kidney-mediated excretion to restore plasma levels.", "population_specificity": "A 36-year-old female with RPGN due to ANCA-associated nephritis and SLE nephritis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:04.692563+00:00"}
{"study_id": 11606, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of D-serine in epileptogenesis by examining the effects of inhibiting or enhancing its metabolism on seizure development and ERK signaling.", "results_summary": "The study found that inhibiting serine racemase (SR) prolonged seizure latencies, shortened durations, and reduced EEG power, while increasing D-serine levels had the opposite effect. These effects were mediated through ERK signaling.", "population_specificity": "Rats and patients with seizures.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:04.744654+00:00"}
{"study_id": 11605, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effect of dopamine depletion on D-serine metabolism in Parkinson's Disease (PD) models and patients, and its potential role in NMDAR transmission.", "results_summary": "The study found that MPTP treatment increased D-serine in monkey putamen, while L-DOPA restored D-serine levels. Dopaminergic denervation was associated with reduced D-serine in the substantia nigra, suggesting D-serine adjuvant therapy may improve nigrostriatal hypoglutamatergic transmission.", "population_specificity": "MPTP-lesioned Macaca mulatta monkeys and PD patients (L-DOPA-free and treated).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:06.069338+00:00"}
{"study_id": 11607, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine if decreased d-Serine expression protects retinal ganglion cells (RGCs) in a glaucomatous animal model and to assess d-Serine and serine racemase (SR) expression levels.", "results_summary": "The study found increased d-Serine and SR expression in glaucomatous retinas, and DAAO treatment (which reduces d-Serine) significantly improved RGC survival. Excess d-Serine did not worsen RGC loss.", "population_specificity": "Rat chronic intraocular hypertension (COH) model (glaucomatous animal model).", "effective_dosage": "Not specified", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:08.837995+00:00"}
{"study_id": 11608, "supplement_id": 1066, "safety_score": "30", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to investigate the relationship between plasma kinetics of D-Serine and its nephrotoxicity in rats.", "results_summary": "The study found that D-Serine administration led to dose-dependent kidney injury in rats, with histological changes observed at doses of 1.8-4.8 mmol/kg bw. Plasma creatinine levels increased significantly when D-Serine Cmax exceeded ~2 \u03bcmol/ml, suggesting Cmax as a predictor of nephrotoxicity.", "population_specificity": "Male Wistar rats", "effective_dosage": "0.1 mmol/kg bw (iv), 0.6-4.8 mmol/kg bw (ip), oral bioavailability estimated at 94%", "study_duration": "24 hours post-administration", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:10.115011+00:00"}
{"study_id": 11609, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine how D-serine influences contextual fear memory extinction at different timings (immediate, delayed, and post-retrieval) in mice with reduced D-serine levels.", "results_summary": "The study found that D-serine deficiency impaired post-retrieval extinction (P-RE) but facilitated immediate extinction (IE) of contextual fear memory, with no effect on delayed extinction (DE). Administering D-serine rescued impaired P-RE and normalized AMPAR expression in the hippocampus.", "population_specificity": "Wild-type and serine racemase knockout (SRRKO) mice with 90% reduced hippocampal D-serine levels.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:10.489201+00:00"}
{"study_id": 11610, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether cognitive training-induced improvements in cognition in schizophrenia patients were associated with increases in serum D-serine levels.", "results_summary": "The study found that schizophrenia patients had lower baseline D-serine levels than healthy controls. In the cognitive training group, increased D-serine levels were positively correlated with improvements in global cognition and verbal learning, but no such associations were observed in the control group.", "population_specificity": "90 outpatients with schizophrenia and 53 healthy controls.", "effective_dosage": "Not specified", "study_duration": "50 hours of cognitive training or computer games control condition.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:11.195908+00:00"}
{"study_id": 11611, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of CBIO, an inhibitor of D-amino acid oxidase (DAAO), which elevates endogenous D-serine levels, on cognitive and motor outcomes in a mouse model of traumatic brain injury (TBI).", "results_summary": "A single treatment with CBIO 24 hours post-injury significantly improved cognitive and motor function, reduced lesion volume and inflammation, and increased hippocampal volume and neuron count. CBIO also enhanced NMDAR subunits and affected CREB, phospho-CREB, and BDNF pathways.", "population_specificity": "Mice with closed head traumatic brain injury (TBI).", "effective_dosage": "Not specified", "study_duration": "Single treatment at 24 hours post-injury", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:11.694263+00:00"}
{"study_id": 11613, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine if basal D-serine (DSR) levels correlate with PTSD symptom severity and predict clinical response to combined TIMBER-Ket therapy.", "results_summary": "Higher basal DSR levels were associated with greater PTSD symptom severity and shorter duration of therapeutic response. DSR levels may serve as a biomarker for PTSD severity and treatment response prediction.", "population_specificity": "20 patients with PTSD", "effective_dosage": "Not specified", "study_duration": "Response duration measured (TIMBER-K: 34.44 \u00b1 19.12 days; TIMBER-P: 16.50 \u00b1 11.39 days)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:13.397243+00:00"}
{"study_id": 11612, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine how D-Serine affects the expression of proteins linked to schizophrenia (NOS1AP, D2 receptor, DISC1) and whether it reverses NOS1AP-mediated dendrite branching deficits.", "results_summary": "D-Serine reduced NOS1AP and DISC1 expression in male rats, increased DISC1 in females, and rescued NOS1AP-induced dendrite branching deficits in vitro, unlike antipsychotics.", "population_specificity": "Male and female Sprague Dawley rats, cortical neurons in vitro.", "effective_dosage": "Not specified.", "study_duration": "12 days (in vivo), 24 hours (in vitro).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:13.671654+00:00"}
{"study_id": 11614, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to review the role of D-Serine in cognitive processes and its potential for aiding diagnosis and therapy in conditions like schizophrenia, Alzheimer's disease, depression, and aging.", "results_summary": "The abstract highlights D-Serine's role in modulating synaptic plasticity and cognitive processes via NMDA-glutamate receptors but notes that its therapeutic potential remains unrealized in clinical practice due to unresolved questions about pharmacokinetics, side effects, and efficacy strategies.", "population_specificity": "Not specified (general focus on cognitive impairment in schizophrenia, Alzheimer's disease, depression, and aging).", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:16.112110+00:00"}
{"study_id": 11615, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine if D-Serine exerts antidepressant-like effects via the AMPAR-mTOR signaling pathway, similar to ketamine.", "results_summary": "A single high dose of D-Serine produced antidepressant-like effects mediated by rapid AMPAR-induced mTOR signaling and increased BDNF proteins, mirroring ketamine's effects. D-Serine also enhanced AMPAR insertion and NMDAR internalization, unlike the control antidepressant desipramine.", "population_specificity": "Rats", "effective_dosage": "Single high dose (specific amount not stated)", "study_duration": "Single administration", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:17.708123+00:00"}
{"study_id": 11616, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether D-serine could attenuate hypofunction of mutant GluN2B-containing NMDARs and improve clinical outcomes in a Rett-like encephalopathy patient.", "results_summary": "D-serine supplementation improved motor, cognitive, and communication functions in the patient after 17 months, suggesting it effectively counteracted NMDAR hypofunction caused by the GRIN2B mutation.", "population_specificity": "A 4-year-old Rett-like encephalopathy patient with a GRIN2B(p.P553T) mutation.", "effective_dosage": "Not specified", "study_duration": "17 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:18.607744+00:00"}
{"study_id": 11617, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether d-serine modulates NMDAR-mediated neurotransmission during neural circuit development and its role in synaptic maturation and axon stabilization.", "results_summary": "The study found that d-serine promotes glutamatergic synapse maturation and stabilizes axonal inputs, while its degradation impairs synaptic maturation. Elevated d-serine levels led to expanded visual receptive fields, suggesting a role in circuit refinement.", "population_specificity": "Xenopus tadpole visual system", "effective_dosage": "Not specified", "study_duration": "Chronic administration (exact duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:18.884411+00:00"}
{"study_id": 11618, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the effects of continuous (daily) NMDAR agonists, specifically D-Serine, on auditory mismatch negativity (MMN), clinical symptoms, and neurocognition in individuals with schizophrenia/schizoaffective disorder.", "results_summary": "Double-blind D-Serine treatment significantly improved MMN frequency and clinical symptoms, with large effect sizes. Open-label D-Serine showed similar results, while bitopertin (a glycine transport inhibitor) had no significant effects.", "population_specificity": "Individuals with schizophrenia/schizoaffective disorder.", "effective_dosage": "60mg/kg/d (double-blind), 30-120mg/kg/d (open-label).", "study_duration": "6 weeks (double-blind).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:20.710277+00:00"}
{"study_id": 11619, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether endogenous sulfhydration signaling, particularly involving H2S and D-Serine, is essential for long-term potentiation (LTP) and memory.", "results_summary": "The study found that H2S and polysulfides enhance NMDAR-dependent LTP by maintaining D-Serine availability via sulfhydration of serine racemase (SR). In aged rats, H2S supplementation restored SR sulfhydration and improved age-related LTP deficits, suggesting a therapeutic potential for neurocognitive dysfunction.", "population_specificity": "Aged rats (animal model).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:21.274013+00:00"}
{"study_id": 11620, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the impact of pregabalin (PGB) on spinal d-serine content and NMDA receptor-mediated synaptic transmission in neuropathic mice.", "results_summary": "PGB treatment reduced spinal d-serine content, decreased NMDA receptor-mediated synaptic transmission, and attenuated mechanical allodynia. Exogenous d-serine counteracted PGB's effects, suggesting d-serine's role in modulating PGB's antinociceptive action.", "population_specificity": "Peripheral nerve-ligated neuropathic mice.", "effective_dosage": "50 mg/kg of PGB.", "study_duration": "5 days.", "interactions": "PGB (pregabalin) and d-serine.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:22.788601+00:00"}
{"study_id": 11621, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether D-serine supplementation during juvenile and adolescent stages could prevent cognitive deficits and schizophrenia symptoms in adult offspring after maternal immune activation.", "results_summary": "D-serine supplementation (600 mg/L) prevented cognitive deficits in adult offspring exposed to prenatal immune activation, with significant effects observed. The study suggests early D-serine intervention may prevent psychosis in high-risk individuals.", "population_specificity": "Juvenile and adolescent offspring of mice exposed to maternal immune activation (poly(I:C)).", "effective_dosage": "600 mg/L in drinking water", "study_duration": "From postnatal day 28 (P28) to postnatal day 56 (P56)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:22.923064+00:00"}
{"study_id": 11622, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether D-Serine could restore spine dynamics, adaptive plasticity, and cognitive deficits in amyloid precursor protein knockout (APP-KO) mice by normalizing D-serine homeostasis.", "results_summary": "Chronic D-serine treatment normalized D-serine homeostasis, restored spine dynamics and morphology, and rescued cognitive deficits in APP-KO mice, suggesting its role in maintaining synaptic plasticity.", "population_specificity": "Adult amyloid precursor protein knockout (APP-KO) mice", "effective_dosage": "Not specified", "study_duration": "Chronic treatment (exact duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:24.598627+00:00"}
{"study_id": 11623, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether D-Serine levels are decreased in schizophrenia patients and if D-Serine supplementation combined with antipsychotics improves symptoms.", "results_summary": "The meta-analysis found significantly decreased serum D-Serine levels in schizophrenia patients and that D-Serine therapy combined with antipsychotics improved both negative and positive symptoms. However, clinical methodological heterogeneity was noted as a limitation.", "population_specificity": "Patients with schizophrenia", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:26.152576+00:00"}
{"study_id": 11624, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the pharmacological profile of a novel asc-1 inhibitor (ACPP) and its potential to regulate extracellular D-Ser levels as a treatment strategy for schizophrenia.", "results_summary": "ACPP effectively inhibited D-Ser uptake in human asc-1-expressing cells and rat neurons but not in astrocytes. It decreased extracellular D-Ser levels in the hippocampus, contrasting with another asc-1 inhibitor (SMLC), which increased them.", "population_specificity": "Rat primary neurons and astrocytes, human asc-1-expressing CHO cells", "effective_dosage": "IC50 values of 0.72 \u00b1 0.13 \u03bcM (human cells) and 0.89 \u00b1 0.30 \u03bcM (rat neurons)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:28.436805+00:00"}
{"study_id": 11625, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to develop and validate an LC-MS/MS-based method for determining D-serine levels in human serum.", "results_summary": "The study successfully developed a precise and sensitive LC-MS/MS method for quantifying D-serine in human serum, with a linear calibration range of 0.5-5.0 \u03bcM and a detection limit of 1.1 fmol/injection. The method demonstrated stable retention times and adequate precision and recovery for clinical research applications.", "population_specificity": "Human serum samples (specific population not detailed).", "effective_dosage": "Not applicable (method validation study).", "study_duration": "Not applicable (method validation study).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:28.782443+00:00"}
{"study_id": 11627, "supplement_id": 1066, "safety_score": "75", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to assess the effects of D-serine on negative symptoms in individuals at clinical high risk of schizophrenia.", "results_summary": "D-serine significantly improved negative symptoms by 35.7% compared to placebo, with a mean final SOPS negative score of 7.6 vs. 11.3 for placebo. Adverse events led to discontinuation in some participants, but the study supports NMDAR-based interventions for prodromal symptoms.", "population_specificity": "Individuals aged 13-35 at clinical high risk of schizophrenia with a SOPS score >20.", "effective_dosage": "60 mg/kg orally in divided daily doses.", "study_duration": "16 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:30.173322+00:00"}
{"study_id": 11626, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine whether co-administration of D-serine with DAAO inhibitors could lower the required D-serine dose for treating schizophrenia by enhancing its bioavailability.", "results_summary": "In rodents, DAAO inhibitors increased plasma and brain D-serine levels, but this effect was not observed in monkeys or dogs, suggesting species-specific differences in D-serine metabolism. The findings caution against assuming DAAO inhibition will enhance D-serine efficacy in humans.", "population_specificity": "Rodents (mice), monkeys, and dogs.", "effective_dosage": "High doses of D-serine (specific amounts not provided).", "study_duration": "Not specified.", "interactions": "DAAO inhibitors (structurally distinct compounds).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:30.446216+00:00"}
{"study_id": 11628, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the role of D-Serine in the development of mechanical allodynia induced by spinal Sig-1R activation in neuropathic mice.", "results_summary": "The study found that D-Serine production and Srr expression increased post-CCI surgery, localized to astrocytes and neurons. Blocking Srr or degrading D-Serine reduced mechanical allodynia, and Sig-1R antagonist effects were reversed by exogenous D-Serine.", "population_specificity": "Chronic constriction injury (CCI) mice.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:31.370428+00:00"}
{"study_id": 11629, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether neonatal deficits in NMDA-receptor-mediated neurotransmission, specifically involving D-serine, affect adult brain functions and behavior, and whether neonatal D-serine supplementation could rescue these deficits.", "results_summary": "The study found that Pick1 knockout mice with neonatal D-serine deficits exhibited behavioral and electrophysiological deficits in adulthood, which were rescued by transient neonatal D-serine supplementation but not by adult treatment. These results suggest a critical role for D-serine in neurodevelopment.", "population_specificity": "Pick1 knockout mice with neonatal- and forebrain-specific D-serine deficits.", "effective_dosage": "Not specified", "study_duration": "Transient neonatal supplementation (exact duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:32.056567+00:00"}
{"study_id": 11630, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether D-Serine, a glutamate agonist, could effectively suppress tics in children with Tourette syndrome compared to a placebo and riluzole.", "results_summary": "The study found that D-Serine showed no significant difference in tic suppression compared to placebo, with a mean percent improvement of 39.5 in the combined Yale Global Tic Severity Scale score and 25.0 in total tic scores. The results suggest D-Serine is not effective for tic suppression in this population.", "population_specificity": "Children with Tourette syndrome (ages 9-18, predominantly male).", "effective_dosage": "Maximum dose of 30 mg/kg/day.", "study_duration": "6 weeks of treatment followed by a 2-week taper.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:34.225633+00:00"}
{"study_id": 11631, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether exogenous d-serine could rescue impairments in hippocampal synaptic plasticity and memory caused by sodium fluoroacetate (FAC).", "results_summary": "The study found that FAC impaired spatial learning, memory, and hippocampal LTP, but exogenous d-serine successfully reversed these deficits, suggesting its essential role in synaptic plasticity and memory.", "population_specificity": "Not specified (animal study, likely rodents based on methodology).", "effective_dosage": "Not specified for d-serine (FAC dosage: 3mg/kg, i.p.).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:34.859192+00:00"}
{"study_id": 11632, "supplement_id": 1066, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether PEG-conjugated Dsd1p (PEG-Dsd1p) could effectively reduce D-serine levels in vivo as a potential therapeutic strategy for neurological disorders involving NMDA receptor overstimulation.", "results_summary": "PEG-Dsd1p retained enzyme activity and stability, extended serum half-life, reduced immunogenicity, and effectively decreased D-serine levels in the mouse hippocampus.", "population_specificity": "Mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:36.527350+00:00"}
{"study_id": 64819, "supplement_id": 1087, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to test the effects of residing in an evening blue-depleted light environment on melatonin levels, sleep, neurocognitive arousal, sleepiness, and potential side effects.", "results_summary": "Melatonin levels were less suppressed in the blue-depleted light environment (15%) compared to standard lighting (45%), and total sleep time and REM sleep were longer. No significant differences in subjective sleepiness or side effects were observed.", "population_specificity": "12 healthy adults", "effective_dosage": "Not Assessed", "study_duration": "5 days in each light environment", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:44.920804+00:00"}
{"study_id": 64817, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether abnormal activities of \u03b3\u03b4T-cells may be involved in alopecia areata (AA) pathogenesis.", "results_summary": "The study found that skin-resident \u03b3\u03b4T-cells, particularly V\u03b41 subsets, were activated and infiltrated hair follicles in AA, suggesting their potential role in AA pathobiology. These cells released IFN-\u03b3 even around non-lesional hair follicles, indicating early involvement in the disease.", "population_specificity": "Human healthy, lesional, and non-lesional AA scalp biopsies.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:45.006433+00:00"}
{"study_id": 64814, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether timed bright light treatment could reduce subjective and objective sleepiness in hospital nurses during three consecutive night shifts.", "results_summary": "Bright light treatment reduced heavy eyelids during night shifts but did not significantly affect KSS or PVT scores. It also did not impede readaptation to a day-oriented rhythm after the night shifts.", "population_specificity": "Hospital nurses working three consecutive night shifts.", "effective_dosage": "Bright light (10,000 lux) and red dim light (100 lux) for 30 minutes per night.", "study_duration": "Nine days (three days before, three night shifts, and three days after).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:45.488779+00:00"}
{"study_id": 64815, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 80, "study_goal": "The researchers aimed to determine whether dim red light (DRL) therapy could improve diurnal cortisol patterns and reduce fatigue in post-treatment cancer survivors.", "results_summary": "The study found that both bright white light and dim red light groups showed moderate improvements in cortisol slope and output, but these changes did not mediate the relationship between light therapy and fatigue reduction.", "population_specificity": "Post-treatment adult cancer survivors with cancer-related fatigue.", "effective_dosage": "Daily use for 30 minutes.", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:45.749689+00:00"}
{"study_id": 64816, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether preoperative upper airway ultrasound measurements, including hyomental distance (DIM), could predict difficult face mask ventilation.", "results_summary": "The study found that hyomental distance with hyperextension of the head and subluxation of the mandible (DIMs) had a predictive role in curarized patients as a protective parameter for difficult mask ventilation.", "population_specificity": "250 adult patients selected for colorectal, gastric, bariatric, and pancreatic elective surgery.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:46.022551+00:00"}
{"study_id": 64818, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to evaluate changes in chronobiologic sleep parameters, specifically the phase angle between peak cortisol and dim-light melatonin onset (DLMO), in patients with MDD receiving adjunctive brexpiprazole.", "results_summary": "The study found an increase in the phase angle between peak cortisol and DLMO by 108 minutes and an improvement in BRIAN Total score by -14.6 points after 8 weeks of adjunctive brexpiprazole treatment. A moderate-to-high correlation was observed between the change in phase angle and BRIAN Total score.", "population_specificity": "Patients with major depressive disorder (MDD) and inadequate response to antidepressant treatment who were experiencing sleep disturbances.", "effective_dosage": "2-3 mg/day", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:46.396970+00:00"}
{"study_id": 64820, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 47, "quality_score": 82, "study_goal": "The researchers aimed to examine the efficacy of adjunctive bright light therapy (BLT) compared to dim red light (DRL) with a gradual timing advance protocol in improving remission rates and reducing depression severity in patients with non-seasonal unipolar depression and evening chronotype.", "results_summary": "The study found that bright light therapy (BLT) resulted in a higher cumulative remission rate (67.4%) compared to dim red light (DRL) (46.7%) and a shorter time to remission. However, the abstract does not provide detailed statistical significance or effect size for DRL's efficacy.", "population_specificity": "Unipolar non-seasonal depressed patients with evening chronotype (93 participants, 80% female, mean age 46.4 \u00b1 11.7 years).", "effective_dosage": "Not specified (only mentions \"dim red light\" without dosage details).", "study_duration": "5 weeks of intervention, with follow-up until 5 months post-treatment.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:47.605927+00:00"}
{"study_id": 64821, "supplement_id": 1087, "safety_score": "75", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the immunologic and clinical activity, as well as the safety profile, of CSF-1R inhibition using the monoclonal antibody LY3022855 in patients with advanced metastatic breast cancer or metastatic castration-resistant prostate cancer.", "results_summary": "LY3022855 was well tolerated and showed evidence of immune modulation, with clinically meaningful stable disease observed in two patients with metastatic breast cancer for over nine months. Circulating CSF-1 levels increased, and proinflammatory monocytes were affected by day 8.", "population_specificity": "Patients with advanced refractory metastatic breast cancer (MBC) or metastatic castration-resistant prostate cancer (mCRPC).", "effective_dosage": "Cohorts A (1.25 mg/kg every 2 weeks), B (1.0 mg/kg on weeks 1, 2, 4, and 5), C (100 mg once weekly), D (100 mg every 2 weeks).", "study_duration": "6-week cycles (exact duration per patient not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:47.821454+00:00"}
{"study_id": 64822, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether bright light exposure improves sleep quality by altering functional connectivity in the salience network, compared to dim light exposure.", "results_summary": "Bright light exposure improved sleep efficiency and latency compared to dim light exposure and decreased functional connectivity in the salience network. The study suggests bright light may modulate brain connectivity to enhance sleep quality.", "population_specificity": "30 individuals with sleep disturbances", "effective_dosage": "1 hour of dim light (<300 lux) exposure daily", "study_duration": "2 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:53.356951+00:00"}
{"study_id": 64826, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to investigate the immune mechanism of peg-IFN-\u03b1 and NA combination therapy in reducing HBsAg in NA-experienced CHB patients.", "results_summary": "The study enrolled 40 NA-experienced CHB patients and analyzed frequencies of peripheral blood NK cells and DCs, but the abstract does not provide specific results regarding DIM.", "population_specificity": "NA-experienced chronic hepatitis B (CHB) patients", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:53.847432+00:00"}
{"study_id": 64823, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to standardize and evaluate CD30 intensity by flow cytometry (FCM) in non-Hodgkin's lymphomas to improve detection and treatment with brentuximab vedotin (BV).", "results_summary": "FCM distinguished four groups of CD30 expression levels and was more sensitive than IHC in 11% of cases, particularly in DLBCL. The study found that standardized FCM could enhance case detection and potentially extend BV treatment to various CD30-positive lymphomas.", "population_specificity": "Patients with non-Hodgkin's lymphomas (161 cases analyzed across 12 centers).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:53.986938+00:00"}
{"study_id": 64825, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to determine whether a polymorphism in the PERIOD3 gene (PER3; rs57875989) influenced the sleep-promoting effects of melatonin in individuals with Delayed Sleep-Wake Phase Disorder (DSWPD).", "results_summary": "The abstract does not provide specific results regarding DIM's effects, only mentioning the collection of buccal swabs for genotyping in individuals with DSWPD and delayed dim light melatonin onset (DLMO).", "population_specificity": "104 individuals (53 males; mean age 29.4 \u00b1 10.0 years) with DSWPD and delayed DLMO.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:54.339089+00:00"}
{"study_id": 64824, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were attempting to determine the feasibility and acceptability of bright white light (BWL) therapy for reducing fatigue in adolescent/young adult (AYA) oncology patients receiving cancer-directed therapy.", "results_summary": "The study found that BWL therapy was feasible and acceptable, with no extreme treatment-emergent effects compared to dim red light (DRL). Patients in the BWL group showed significant improvement in fatigue outcomes, unlike the DRL group.", "population_specificity": "Adolescent/young adult (AYA) oncology patients with newly diagnosed solid tumors, including lymphoma.", "effective_dosage": "30 minutes daily upon awakening.", "study_duration": "8 weeks.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:54.776679+00:00"}
{"study_id": 64829, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review and categorize circadian measurement tools (such as dim light melatonin onset) for use in bipolar disorder research and clinical practice.", "results_summary": "The study described measurement approaches for circadian function in bipolar disorder, proposed a taxonomy distinguishing circadian measures from constructs, and emphasized the need for systematic measurement to improve reproducibility and clinical application.", "population_specificity": "Researchers and clinicians focusing on bipolar disorder and circadian rhythms.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:56.633243+00:00"}
{"study_id": 64827, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to investigate the presence of endothelial progenitor cells (EPCs) in patients with moyamoya disease (MMD) and explore their role in neovascularization following encephaloduroarteriosynangiosis (EDAS).", "results_summary": "The study analyzed blood samples from MMD patients using flow cytometry to identify EPCs (defined as CD34+), but the abstract does not report specific findings regarding DIM or its effects.", "population_specificity": "Patients diagnosed with moyamoya disease (MMD).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:56.815220+00:00"}
{"study_id": 64828, "supplement_id": 1087, "safety_score": "90", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine whether bright light therapy (BLT), including dim light BLT, is effective in reducing depressive symptoms in adults with intellectual disabilities compared to usual care.", "results_summary": "Both BLT groups showed a significant decrease in depressive symptoms, though no significant differences were found between dim light BLT and no-BLT. The 10,000 lux BLT reduced symptoms below the clinical cut-off point, suggesting potential clinical relevance.", "population_specificity": "Adults with intellectual disabilities and depressive symptoms.", "effective_dosage": "30 minutes of dim light BLT in the morning for 14 consecutive days.", "study_duration": "14 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:39:56.910289+00:00"}
{"study_id": 64831, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to characterize the acute and chronic effects of electroconvulsive therapy (ECT) on immune cell subsets in depressed patients to understand its therapeutic mechanism and predict treatment response.", "results_summary": "The study found differences in the relative proportion of putative immunoregulatory CD56 cells between ECT remitters and non-remitters, suggesting immune modulation may play a role in treatment response.", "population_specificity": "Depressed patients (n=21) who underwent ECT.", "effective_dosage": "Not mentioned", "study_duration": "Blood was withdrawn before and after the first and last ECT session.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:01.712570+00:00"}
{"study_id": 64832, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to investigate the influence of HLA-B*57:01 on CD8 T-cell exhaustion and HIV-specific immune responses during untreated HIV infection.", "results_summary": "The study found that HLA-B*57:01-restricted CD8 T-cell responses exhibited beneficial functional patterns and lower inhibitory receptor expression (PD-1 and TIGIT) early in HIV infection compared to other HLA class I alleles. However, CD8 T-cell exhaustion progressed in both groups over time.", "population_specificity": "HIV-infected individuals with and without the HLA-B*57:01 allele.", "effective_dosage": "Not mentioned", "study_duration": "Longitudinal follow-up after peak viremia control (specific duration not stated).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:03.240243+00:00"}
{"study_id": 64834, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers sought to characterize acute alterations of circadian rhythms in critically ill patients and evaluate associations between brain dysfunction, systemic multiple organ dysfunction, environmental stimuli, rest-activity rhythms, and melatonin secretion profiles.", "results_summary": "The study found that encephalopathy severity and adrenergic agonist medication exposure were primary factors contributing to abnormal melatonin rhythms, with improvements in encephalopathy not rapidly normalizing rhythms. Urinary 6-sulphatoxymelatonin was not a reliable measure of central circadian rhythm in critically ill patients.", "population_specificity": "Critically ill patients with either intracerebral hemorrhage or sepsis, along with healthy controls.", "effective_dosage": "Not available", "study_duration": "24-48 hours of observation", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:03.534502+00:00"}
{"study_id": 64835, "supplement_id": 1087, "safety_score": "90", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to investigate the safety and efficacy of intrarenal artery infusion of autologous peripheral-blood-derived CD34+ cells for patients with chronic kidney disease (CKD stages III or IV).", "results_summary": "The study found that CD34+ cell therapy was safe, with no adverse events reported, and improved 1-year outcomes, including increased circulating endothelial progenitor cells and reduced inflammatory markers.", "population_specificity": "Patients with chronic kidney disease (CKD stages III or IV).", "effective_dosage": "2.5 \u00d7 10^5 cells/kg (treatment group).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:04.859551+00:00"}
{"study_id": 64839, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to assess the immunological impact of anti-PD-1 (nivolumab) treatment on peripheral blood T-cell subpopulations in patients with oral cavity squamous cell carcinoma (OCSCC).", "results_summary": "Nivolumab treatment led to a decline in the frequency of blood CD4+ T-cells and opposing effects on CD4+ and CD8+ T-cell populations, though clinical responses were not evaluated.", "population_specificity": "10 patients with oral cavity squamous cell carcinoma (OCSCC).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:04.971812+00:00"}
{"study_id": 64833, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to determine whether controlled home-based bright white light therapy (BWLT) is feasible, tolerable, and effective for managing fatigue in multiple sclerosis (MS) patients compared to dim red light therapy (DRLT).", "results_summary": "Both BWLT and DRLT significantly reduced fatigue scores (FSS) compared to baseline, but there was no significant difference between the two groups, suggesting a strong placebo effect for DRLT. Quality of life metrics also improved in both arms without significant between-group differences.", "population_specificity": "Adults with MS-associated fatigue (average age 42 years, 80% female).", "effective_dosage": "Twice-daily 1-hour sessions (BWLT: 10,000 lx; DRLT: <300 lx).", "study_duration": "4-week intervention period.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:05.610333+00:00"}
{"study_id": 64838, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to compare changes in immune checkpoint protein levels (Tim-3/Gal-9 and PD-1/PD-L1) in peripheral blood between pregnant and nonpregnant women after blastocyst transfer.", "results_summary": "In women who conceived, Tim-3 and PD-1 expression on peripheral lymphocytes decreased significantly on days 3 and 6 post-transfer but returned to baseline by day 9. No significant changes were observed in nonpregnant women.", "population_specificity": "Fifty-one infertile women undergoing day-5 blastocyst transfer.", "effective_dosage": "Not mentioned", "study_duration": "9 days (measurements taken on days 0, 3, 6, and 9)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:06.549424+00:00"}
{"study_id": 64837, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to assess the feasibility of a larger-scale trial testing bright light therapy (not DIM) for depressive symptoms in cardiac patients.", "results_summary": "The trial was terminated early due to low enrollment rates (1-2 participants/month), with only 39.5% of the target sample size achieved. Once enrolled, most participants adhered to the assigned treatment and completed follow-up.", "population_specificity": "Cardiac patients hospitalized for acute coronary syndrome or undergoing cardiac surgery.", "effective_dosage": "Bright light (10,000 lux) or dim light placebo (500 lux) for 30 minutes daily.", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:06.716490+00:00"}
{"study_id": 64840, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to determine the prevalence of circadian rhythm sleep-wake disorders (CRSWDs) in individuals with chronic insomnia symptoms following mild traumatic brain injury (mTBI).", "results_summary": "The study found that 26% of participants had a CRSWD, with delayed sleep-wake phase disorder being the most common diagnosis (20%). The findings highlight the importance of circadian assessment in mTBI patients with chronic insomnia.", "population_specificity": "Individuals aged 17-65 years with chronic insomnia symptoms 3-24 months after mild traumatic brain injury (mTBI).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:10.790401+00:00"}
{"study_id": 64841, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to assess the feasibility and preliminary effects of bright light (BL) therapy on sleep in ovarian and endometrial cancer survivors, and explore underlying biologic and chronobiologic factors.", "results_summary": "The study found that BL therapy showed trends toward improving nighttime awakenings, sleep quality, and depression compared to dim light (DL), with medium to large effect sizes, though improvements returned to baseline by 3-month follow-up.", "population_specificity": "Ovarian and endometrial cancer survivors", "effective_dosage": "45 minutes of BL or DL daily", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:11.539399+00:00"}
{"study_id": 64842, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers were attempting to determine whether retinal dysfunction, measured by ERG oscillatory potential implicit times, precedes visible vascular defects in diabetic retinopathy.", "results_summary": "The study found that delays in dark-adapted ERG oscillatory potential implicit times occur in response to dim-flash stimuli before visible vascular defects develop in diabetic retinopathy. This suggests early retinal dysfunction may be detectable prior to clinical signs.", "population_specificity": "Humans and rodents (specific details not provided).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:11.825188+00:00"}
{"study_id": 64845, "supplement_id": 1087, "safety_score": "75", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the efficacy and safety of melatonin for treating sleep onset insomnia in children and adolescents.", "results_summary": "Melatonin significantly advanced sleep onset time and dim light melatonin onset, reduced sleep onset latency, and increased total sleep time, with no significant differences in drop-out rates or severe adverse events.", "population_specificity": "Children and adolescents with sleep onset insomnia", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:12.102116+00:00"}
{"study_id": 64844, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to investigate the potential of plant-based compounds, including DIM, to modulate miRNA expression and gene networks for breast cancer therapy.", "results_summary": "DIM was found to downregulate miR-92a, which modulates NFkB and inhibits cancer development, demonstrating its potential as an anticancer agent.", "population_specificity": "Not specified (literature review of existing studies).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:12.359580+00:00"}
{"study_id": 64847, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the phenotypic and functional characteristics of peripheral blood NK cells in HCC patients following sorafenib treatment.", "results_summary": "The study compared NK cell percentages and cytoplasmic granule production in HCC patients versus healthy donors, assessing associations with mRECIST, time to progression, and median overall survival.", "population_specificity": "60 HCC patients and 45 healthy donors.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:13.667439+00:00"}
{"study_id": 64849, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review recent evidence on the association between chronotype (morning/evening preference) and unipolar depression, focusing on methodological limitations and future research directions.", "results_summary": "The review found that most studies associate evening chronotype with higher depression risk, but the directionality remains unclear. Some evidence suggests misalignment with the biological clock may have a stronger link to depressive symptoms than chronotype alone.", "population_specificity": "Not specified (review of existing studies)", "effective_dosage": "Not available", "study_duration": "Not applicable (review study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:14.475590+00:00"}
{"study_id": 64846, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to identify biomarkers of fingolimod (FTY) treatment response in relapsing-remitting multiple sclerosis (RRMS) patients by examining peripheral immune changes.", "results_summary": "The study found decreased absolute counts of B cells and most T-cell subsets under FTY treatment, with specific changes in senescent CD8+ T cells and CD56+ T cells. Biomarkers for treatment response were explored but not conclusively identified.", "population_specificity": "135 RRMS patients initiating FTY treatment in a 2-year multicentre observational study, with 36 classified as 'Active' or 'Stable' based on clinical/radiological activity.", "effective_dosage": "Not specified", "study_duration": "2 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:15.099546+00:00"}
{"study_id": 64850, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to evaluate changes in monocyte subsets and HLA-DR expression during MP pneumonia in children.", "results_summary": "The study analyzed monocyte subsets in healthy volunteers and MP pneumonia patients at admission and remission stages, but no results specific to DIM were mentioned.", "population_specificity": "Children with MP pneumonia and healthy volunteers.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:18.137431+00:00"}
{"study_id": 64853, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to investigate the frequencies of monocyte subsets in blood and their response to hydroxyurea (HU) therapy in sickle cell anemia (SCA) patients, focusing on their ability to express pro-inflammatory molecules and tissue factor (TF).", "results_summary": "The study identified major changes in monocyte subsets, particularly classical monocytes (CD14++CD16-), but did not report specific findings related to DIM.", "population_specificity": "Sickle cell anemia (SCA) patients", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:19.372293+00:00"}
{"study_id": 64852, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the relationship between HCMV, adaptive NK cell markers, and their potential immunoregulatory role in multiple sclerosis (MS).", "results_summary": "The study found increased proportions of NKG2C(+), FcR\u03b3(-), and PLZF(-) CD56 cells in MS patients, suggesting a potential link between HCMV-induced adaptive NK cells and reduced MS disability progression.", "population_specificity": "Controls and MS patients, considering HCMV serology and clinical features.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:19.435036+00:00"}
{"study_id": 64857, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to develop a method (INTime) for continuous and reliable circadian phase estimation in real time to personalize treatment timing.", "results_summary": "The study found that individual circadian phases varied widely among participants, and the INTime algorithm accurately predicted core temperature bathyphase for most subjects, enabling potential treatment personalization.", "population_specificity": "33 volunteers stratified by sex and age.", "effective_dosage": "Not available", "study_duration": "Measurements were taken over 7 days.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:21.474167+00:00"}
{"study_id": 64856, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the feasibility and effects of a weight-loss intervention (caloric restriction and aerobic exercise) on tumor markers and gene expression in overweight/obese breast cancer patients.", "results_summary": "The weight-loss intervention (WLI) led to significant reductions in weight, body fat, and serum leptin, along with increased physical activity and upregulation of tumor-related genes (PI3Kinase signaling and cell cycle-apoptosis related genes) compared to the attention control arm.", "population_specificity": "Overweight/obese, Stage 0-II breast cancer patients (n=32).", "effective_dosage": "Not specified (intervention focused on caloric restriction and aerobic exercise).", "study_duration": "Approximately 30 days (presurgery).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:21.967055+00:00"}
{"study_id": 64858, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether true acupuncture could be differentiated from sham acupuncture using QST profiles and to assess its effects on pain and functionality in chronic pain participants.", "results_summary": "True acupuncture reduced pain and improved functional status (physical functioning and energy/fatigue) compared to routine care, but QST profiles did not differentiate between true and sham acupuncture.", "population_specificity": "254 healthy or chronic back and neck pain participants (204 analyzed).", "effective_dosage": "Not specified (6 sessions of acupuncture, twice weekly).", "study_duration": "3 weeks (6 sessions).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:22.796925+00:00"}
{"study_id": 64859, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the interplay between sleep and circadian systems and identify atypical circadian rhythm disorders using diagnostic tools like actigraphy and melatonin profilometry.", "results_summary": "The study highlights the utility of 24-hour melatonin mapping and strategic testing to identify circadian rhythm disorders, including iatrogenic hypermelatoninemia, but does not specifically address DIM's effects.", "population_specificity": "Not specified (general discussion of circadian rhythm disorders)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:23.522594+00:00"}
{"study_id": 64860, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were attempting to determine the importance of assessing circadian rhythms and circadian disruption in clinical settings.", "results_summary": "The abstract discusses the significance of circadian rhythms in physiologic functions and the need to assess internal circadian timing for clinical management of circadian rhythm disorders. It does not mention DIM or its effects.", "population_specificity": "Not specified (abstract discusses circadian rhythms broadly).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:25.677413+00:00"}
{"study_id": 64861, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to describe the clinicopathologic features of systemic EBV-associated T-cell lymphoproliferative disorders (S-EBV-T-LPD) in children in the United States.", "results_summary": "The study identified overlapping features among EBV-HLH, S-EBV-TCL, and S-CAEBV in pediatric cases, highlighting diagnostic challenges and poor outcomes with current therapies.", "population_specificity": "Eight children (ages 14 months to 9 years) of Hispanic, Asian, and Caucasian origins with S-EBV-T-LPD.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:27.834659+00:00"}
{"study_id": 64862, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effectiveness of Circadian Reinforcement Therapy (CRT) combined with electronic self-monitoring in preventing sleep-wake cycle drift and depression worsening in patients transitioning from inpatient to outpatient care.", "results_summary": "The study does not report specific results regarding DIM, as it focuses on CRT and its potential benefits for depression management through circadian rhythm stabilization.", "population_specificity": "Patients with Major Depressive Disorder transitioning from inpatient to outpatient care (n=130).", "effective_dosage": "Not applicable (intervention involved behavioral therapy and monitoring, not DIM supplementation).", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:28.375469+00:00"}
{"study_id": 64866, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review therapeutic advances, current dilemmas, and future directions for treating advanced hepatocellular carcinoma (HCC).", "results_summary": "The study summarizes clinical treatment options for advanced HCC, including surgery, radiotherapy, and emerging therapies like molecular targeted therapy and immunotherapy, but does not specifically address DIM.", "population_specificity": "Patients with advanced hepatocellular carcinoma (HCC).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:30.039216+00:00"}
{"study_id": 64854, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to assess the efficacy of bright light therapy (BLT) in treating seasonal affective disorder (SAD) in adults by comparing it to dim light or placebo.", "results_summary": "BLT was found to be superior to placebo, with a standardized mean difference of -0.37 for depression ratings and a risk ratio of 1.42 for treatment response, though the studies showed moderate heterogeneity and risk of bias.", "population_specificity": "Adults with seasonal affective disorder (SAD).", "effective_dosage": "Bright light therapy (\u22651,000 lx) via light box or light visor.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:31.035590+00:00"}
{"study_id": 64867, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the feasibility of detecting and quantitating PNH cells in bone marrow using flow cytometry with FLAER and antibodies against GPI-anchored proteins.", "results_summary": "The study found that careful flow cytometry analysis of bone marrow aspirates can provide results for PNH detection and quantitation equivalent to those obtained with peripheral blood, particularly useful in patients with unsuspected PNH or severe cytopenia.", "population_specificity": "Patients with paroxysmal nocturnal hemoglobinuria (PNH) or severe cytopenia.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:31.907298+00:00"}
{"study_id": 64865, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the safety and efficacy of combining radiochemotherapy (RCT), mHsp70-targeting NK cells, and PD-1 inhibition in a patient with advanced NSCLC.", "results_summary": "The combined therapy was well tolerated, resulted in superior overall survival, and led to long-term tumor control with no viable tumor cells detected post-therapy. Immune cell infiltration increased significantly, and no tumor progression or metastases were observed 33 months post-diagnosis.", "population_specificity": "A single patient with inoperable NSCLC (cT4, cN3, cM0, stage IIIb).", "effective_dosage": "4 cycles of autologous ex vivo TKD/IL-2-activated NK cells and PD-1 antibody nivolumab.", "study_duration": "33 months (follow-up period).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:31.928497+00:00"}
{"study_id": 64864, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to identify risk factors for choroidal nevus transformation into melanoma using multimodal imaging and review current treatment options, including the mnemonic TFSOM-DIM.", "results_summary": "The study found that specific factors (thickness >2mm, subretinal fluid, vision loss, orange pigment, melanoma hollow, diameter >5mm) predicted nevus transformation into melanoma, with risk increasing with the number of factors. Plaque radiotherapy showed tumor control but significant vision loss, while a novel nanoparticle therapy (AU-011) is under investigation.", "population_specificity": "Patients with choroidal nevi (n=3806) monitored for transformation into melanoma.", "effective_dosage": "Not mentioned", "study_duration": "5- and 10-year follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:31.977080+00:00"}
{"study_id": 64868, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to validate a new diagnostic and prognostic indicator for malignant pleural effusion (MPE) based on NK cell subpopulations in pleural fluid and peripheral blood.", "results_summary": "The study found that PF/PB ratios of certain NK subpopulations (CD56 bright CD16-, CD56 dim CD16-, CD16+, and CD57+) were higher in MPEs and paramalignant effusions, with some ratios showing prognostic value. The CD16+ NK ratio had the highest hazard ratio in adjusted analysis, and a decision tree identified lung mass and CD56 dim CD16+ NK ratio as key predictors of survival.", "population_specificity": "71 patients with malignant, paramalignant, or benign pleural effusion.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:36.038567+00:00"}
{"study_id": 64870, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether a metacognitive group intervention based on Toglia's dynamic interactional model could improve real-world functioning in individuals with schizophrenia.", "results_summary": "The intervention group showed significant improvements in performance, participation, and everyday functions post-intervention and at follow-up compared to the control group, suggesting the intervention effectively enhanced real-world functioning.", "population_specificity": "84 participants with schizophrenia (41 controls, 43 intervention).", "effective_dosage": "Not specified", "study_duration": "12-week follow-up (intervention duration not explicitly stated).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:36.742143+00:00"}
{"study_id": 64869, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to identify dynamic lighting configurations that better support psychophysiological wellbeing indicators during morning work periods in a windowless tropical workplace compared to constant lighting.", "results_summary": "Dynamic lighting configurations (500lx increased to 750lx and 500lx increased to 1000lx) improved alertness, cognitive performance, positive affect, and visual comfort while suppressing urinary 6-sulfatoxymelatonin better than constant lighting. Not all dynamic configurations were effective.", "population_specificity": "Healthy individuals in a windowless open-plan workplace in tropical Malaysia.", "effective_dosage": "Not applicable (lighting conditions: 500lx increased to 750lx or 1000lx).", "study_duration": "2-hour morning exposure.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:37.416568+00:00"}
{"study_id": 64871, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the anticancer properties and mechanisms of I3C and DIM, focusing on their potential to inhibit tumor formation and progression.", "results_summary": "The study found that I3C and DIM inhibit multiple signaling pathways (e.g., HIF-1, NF-\u03baB, IGF-1 receptor) and cell cycle-related proteins, demonstrating anti-proliferative and anti-metastatic effects in human cancer cells. Bioinformatics data supported their potential as markers for early diagnosis and therapeutic targets.", "population_specificity": "Human cancer cells (in vitro and in vivo studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:39.022342+00:00"}
{"study_id": 64874, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "To examine the effect of the SSRI citalopram (30 mg) on the sensitivity of the human circadian system to light.", "results_summary": "A 47% increase in melatonin suppression was observed after citalopram administration, with all participants showing more suppression compared to placebo. Melatonin onset occurred later under normal room light with citalopram.", "population_specificity": "Human participants (specific demographics not detailed in the abstract).", "effective_dosage": "30 mg (single dose).", "study_duration": "Acute (single-dose intervention).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:40.208913+00:00"}
{"study_id": 64872, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine if metformin's cardioprotective effects in type 1 diabetes (T1DM) are mediated by reducing anti-angiogenic microRNAs (miRs).", "results_summary": "The study found that metformin treatment in T1DM patients was associated with changes in specific miRs (miR-222, miR-195, miR-21a, miR-126), which were correlated with endothelial function and vascular repair markers. However, the abstract does not specify the magnitude or clinical significance of these changes.", "population_specificity": "23 T1DM patients without cardiovascular disease (CVD), matched with 9 T1DM patients on standard treatment and 23 controls.", "effective_dosage": "Not specified", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:40.742247+00:00"}
{"study_id": 64875, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "To examine the feasibility, acceptability, and effects of a home-based morning bright light treatment on pain, mood, sleep, and circadian timing in US veterans with chronic low back pain.", "results_summary": "Morning bright light treatment reduced pain intensity, pain behavior, thermal pain threshold sensitivity, PTSD symptoms, and improved sleep quality. Phase advances in circadian timing were associated with reductions in pain interference.", "population_specificity": "Thirty-seven US veterans with medically verified chronic low back pain.", "effective_dosage": "One-hour morning bright light treatment self-administered at home.", "study_duration": "13 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:40.838187+00:00"}
{"study_id": 64873, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the effectiveness of the combined mixed dye and fluorescence (CMF) method with the indocyanine green dye (ICG-D) method for identifying sentinel lymph nodes (SLNs) in breast cancer patients.", "results_summary": "The CMF method achieved a significantly higher SLN detection rate (96.4%) compared to ICG-D (83.7%), particularly in patients aged \u226560 years and those with BMI \u226525 kg/m\u00b2. The procedure was feasible under shadowless surgical light conditions, demonstrating improved efficacy.", "population_specificity": "Patients with stage \u2264IIA breast cancer undergoing breast conservative therapy.", "effective_dosage": "CMF used 5 mg of ICG and 4-8 mg of indigo carmine; ICG-D used 10 mg of ICG.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:42.780701+00:00"}
{"study_id": 64878, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the physiologic functions of the aryl hydrocarbon receptor (AHR) and its potential therapeutic applications, including agonists and antagonists like DIM.", "results_summary": "The study highlights the AHR's role in chemical and microbial defense, stem/progenitor cell homeostasis, and immune modulation in barrier organs, but notes challenges in extrapolating animal findings to humans due to species differences and cellular context dependence.", "population_specificity": "Not specified (focus on general AHR functions and animal models).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:46.006250+00:00"}
{"study_id": 64877, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether Programmed Environmental Illumination (PEI) using bright white light (BWL) or dim white light (DWL) could reduce depression in multiple myeloma patients during autologous stem cell transplant (ASCT) hospitalization.", "results_summary": "The study found that BWL significantly reduced depression development compared to DWL, as evidenced by a significant interaction between time of assessment and light condition. No baseline differences in depression scores were observed between the groups.", "population_specificity": "Multiple myeloma patients undergoing autologous stem cell transplant (ASCT) hospitalization.", "effective_dosage": "Circadian inactive dim white light (DWL) delivered throughout the room from 7 to 10 am daily.", "study_duration": "Daily during hospitalization (specific duration not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:46.349485+00:00"}
{"study_id": 64876, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy and safety of combining sorafenib with modified FOLFOX (mFOLFOX) in patients with advanced hepatocellular carcinoma (HCC).", "results_summary": "The combination showed an improved median time-to-progression (7.7 months) and median overall survival (15.1 months) compared to sorafenib alone, with moderate hepatotoxicity. Biomarker changes suggested a correlation between treatment efficacy and angiogenic factors.", "population_specificity": "Child-Pugh A patients with advanced HCC and no prior systemic therapies.", "effective_dosage": "Sorafenib 400 mg twice daily; mFOLFOX (5-FU 1,200 mg/m\u00b2, oxaliplatin 85 mg/m\u00b2, leucovorin 200 mg/m\u00b2) administered every 2 weeks.", "study_duration": "Not explicitly stated in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:46.891399+00:00"}
{"study_id": 64879, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to investigate whether adding DIM to DNG therapy improves outcomes for endometriosis treatment.", "results_summary": "The study explored DIM's effects in in vitro, ex vivo, and a small human cohort, suggesting potential benefits when combined with DNG, but detailed results were not provided in the abstract.", "population_specificity": "Women with endometriosis (small cohort) and endometrial Ishikawa cells (in vitro/ex vivo).", "effective_dosage": "DIM dosages from 10 (units not specified).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:47.544817+00:00"}
{"study_id": 64882, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the ease of use and effectiveness of the D-EYE digital ophthalmoscope versus a conventional direct ophthalmoscope for retinal screening.", "results_summary": "92% of medical students preferred the D-EYE digital ophthalmoscope, identifying key retinal structures faster and confirming findings more easily. The preference was statistically significant (P < .001).", "population_specificity": "Twenty-five medical students and two undilated volunteer participants.", "effective_dosage": "Not applicable", "study_duration": "Single session (30 minutes of instruction followed by immediate testing).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:48.659899+00:00"}
{"study_id": 64881, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to analyze the effects of AMPK agonists, including potential dietary supplements like DIM, on oocytes, embryos, and stem cells, focusing on metabolic stress and developmental outcomes.", "results_summary": "The study suggests that AMPK agonists, including some dietary supplements, may exhibit toxicity in vitro but could be beneficial in vivo for reproduction, with potential improvements from CoQ10 supplementation to boost ATP production.", "population_specificity": "Cultured oocytes, embryos, and stem cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:49.066523+00:00"}
{"study_id": 64883, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers reviewed the effects of jetlag on sleep and explored management strategies, including melatonin.", "results_summary": "Jetlag disrupts sleep patterns, requiring 4-6 days for recovery; melatonin plays a critical role in circadian rhythm adjustment and is used to restore disrupted sleep.", "population_specificity": "Passengers flying across six or more time zones.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:49.918107+00:00"}
{"study_id": 64880, "supplement_id": 1087, "safety_score": "80", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to test the efficacy of 0.5 mg melatonin combined with behavioral sleep-wake scheduling for improving sleep initiation in patients with Delayed Sleep-Wake Phase Disorder (DSWPD) and a delayed endogenous melatonin rhythm.", "results_summary": "Melatonin treatment combined with behavioral scheduling improved sleep onset by 34 minutes, increased sleep efficiency, reduced sleep-related impairments, and showed greater clinician-rated improvement compared to placebo. Adverse events were mild and similar between groups, but long-term safety and efficacy were not assessed.", "population_specificity": "Clinically diagnosed DSWPD patients with delayed melatonin rhythm relative to desired bedtime (mean age 29.0 years; 62 males).", "effective_dosage": "0.5 mg fast-release melatonin, taken 1 hour before desired bedtime for at least 5 consecutive nights per week.", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:50.885199+00:00"}
{"study_id": 64885, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether enhancing NK cell activity through pre- and probiotics could improve immune response to vaccination in older subjects.", "results_summary": "The abstract does not provide specific results regarding DIM's effects, focusing instead on NK cell activity and immune response modulation in aging populations.", "population_specificity": "Older subjects", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:53.223994+00:00"}
{"study_id": 64884, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to assess the ability of flow cytometry to predict early clinical deterioration and overall survival in patients with sepsis admitted to the ED and ICU.", "results_summary": "The study found that increased circulating IGs at the acute phase of sepsis were linked to clinical worsening, especially when associated with T-cell lymphopenia, suggesting early flow cytometry could help identify high-risk patients.", "population_specificity": "Patients admitted for community-acquired acute sepsis from 11 hospital centers (age 67 \u00b1 48 years).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:55.342074+00:00"}
{"study_id": 64888, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effects of high-dose vitamin D therapy on immune response in patients with Addison's disease.", "results_summary": "The study found that 3 months of cholecalciferol treatment achieved sufficient 25(OH)D levels in most patients, though the abstract does not detail specific immune response outcomes.", "population_specificity": "Patients with Addison's disease (n=13).", "effective_dosage": "4000 IU/day of cholecalciferol.", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:56.166456+00:00"}
{"study_id": 64887, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the potential of indole-3-carbinol (I3C) and its derivative DIM as therapeutic agents targeting microcirculatory dysregulations in conditions like cancer, thrombosis, and inflammation.", "results_summary": "The study found that I3C and DIM influence multiple microcirculatory processes, including angiogenesis, leukocyte-endothelial interactions, cytokine production, ROS generation, thrombus formation, and microvascular leakage, suggesting their potential as lead compounds for drug development.", "population_specificity": "Not specified (review of existing literature).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:56.312277+00:00"}
{"study_id": 64890, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers sought to establish the contribution of NK cells and inhibitory CD163 in the context of PD-L1 and PD-1 interactions in antilymphoma immunity.", "results_summary": "The abstract does not provide specific findings related to DIM.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not available.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:56.889455+00:00"}
{"study_id": 64889, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to examine the association between Type D personality and endothelial dysfunction in patients with coronary artery disease (CAD).", "results_summary": "Type D personality was associated with impaired endothelial function (measured by FMD) in men with CAD, independent of depressive symptoms, and this association persisted over time. No significant association was found between Type D and decreased endothelial progenitor cells (EPCs).", "population_specificity": "180 CAD patients (90% men, mean age 58.0 years).", "effective_dosage": "Not mentioned", "study_duration": "12-week exercise program with follow-up at 3 and 12 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:57.738395+00:00"}
{"study_id": 64886, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to compare clinical outcomes and characteristics of type 2 diabetes patients managed under a Diabetes Integrated Management (DIM) program versus those under Diabetes Specialized Care (DSC).", "results_summary": "DIM patients showed lower HbA1c and creatinine levels compared to DSC patients, with significant improvements in most clinical parameters over time, regardless of the management program. The study concluded that DIM is an efficient and effective approach for long-term diabetes management.", "population_specificity": "Type 2 diabetes patients in the ASLTO3 district, Italy.", "effective_dosage": "Not specified", "study_duration": "2008 to 2014 (6 years)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:40:59.257911+00:00"}
{"study_id": 64891, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 19, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy and safety of bright light therapy (BLT) as an add-on treatment for bipolar depression (BD), comparing it to dim light (DL).", "results_summary": "BLT showed significantly higher response (81% vs. 19%) and remission rates (44% vs. 12.5%) compared to DL, with statistically significant reductions in depression scores. Side effects were similar in both groups, with headache being the most common.", "population_specificity": "Thirty-two outpatients with bipolar depression.", "effective_dosage": "BLT (10000 lux) or DL (<500 lux) administered each morning for 30 minutes.", "study_duration": "Two weeks.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:00.341480+00:00"}
{"study_id": 64892, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were not attempting to determine anything about DIM; the abstract discusses broader issues in psychiatry, including diagnostic and treatment challenges, socioeconomic inequality, and the limitations of the medical model.", "results_summary": "The abstract does not mention DIM or its effects; it focuses on the lack of progress in psychiatry, the impact of socioeconomic inequality on mental health outcomes, and critiques the medical model.", "population_specificity": "Not specified (abstract discusses general psychiatric issues, not a specific population).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:01.647683+00:00"}
{"study_id": 64893, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess the effects of radiotherapy (RT) combined with local autologous NK cell transfer in canine sarcomas, evaluating NK cell homing and cytotoxicity.", "results_summary": "The study found that NK cell homing and cytotoxicity increased following RT in canine sarcoma models, with promising results from a first-in-dog clinical trial, including possible abscopal effects.", "population_specificity": "Canine models of sarcoma", "effective_dosage": "Not specified", "study_duration": "14 days (NK cell expansion period)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:03.876665+00:00"}
{"study_id": 64894, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether systematic morning bright light exposure improves sleep efficiency and quality in fatigued cancer survivors compared to dim red light.", "results_summary": "The study found that bright light exposure significantly improved sleep efficiency over time compared to dim red light, suggesting beneficial effects on sleep in fatigued cancer survivors. Larger efficacy trials were recommended to confirm these findings.", "population_specificity": "Fatigued cancer survivors", "effective_dosage": "30 minutes of light box use every morning", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:04.134686+00:00"}
{"study_id": 64897, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "To evaluate the acute response of natural killer (NK) cell subsets in chronic kidney disease patients undergoing intradialytic exercise compared to a control hemodialysis session.", "results_summary": "Intradialytic exercise prevented the decrease in peripheral frequency of NK cell subsets during hemodialysis therapy and did not exacerbate systemic inflammation or induce muscle damage.", "population_specificity": "Nine chronic kidney disease patients undergoing hemodialysis.", "effective_dosage": "Not specified (single bout of 20-min intradialytic exercise).", "study_duration": "Single session with a 7-day interval between trials.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:05.875582+00:00"}
{"study_id": 64896, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to identify factors reducing the efficacy of ultrasound-guided saline enema (USGSE) for ileocolic intussusception and develop a predictive model for its success.", "results_summary": "The study found a 77% composite reduction rate for USGSE, with initial intussusception location, free peritoneal fluid, and negative Doppler signal significantly linked to failure. A predictive model based on symptom onset, fluid presence, and location reliably identified patients at risk of failure.", "population_specificity": "Patients admitted with ileocolic intussusception (2009\u20132014).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:06.197242+00:00"}
{"study_id": 64895, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the antileukemic activity of a new CD22-targeted CAR T-cell therapy in patients with relapsed/refractory B-ALL, particularly those who had previously received CD19-directed immunotherapy.", "results_summary": "The study observed dose-dependent antileukemic activity, with complete remission achieved in 73% of patients receiving \u22651 \u00d7 10^6 CD22-CAR T cells per kg. The therapy showed promise in cases where CD19 loss had led to resistance.", "population_specificity": "21 children and adults with relapsed/refractory B-ALL, including 17 previously treated with CD19-directed immunotherapy.", "effective_dosage": "\u22651 \u00d7 10^6 CD22-CAR T cells per kg", "study_duration": "Not specified in the abstract", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:06.686640+00:00"}
{"study_id": 64898, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to examine the impact of bright white light (BWL) versus dim red light (DRL) therapy on fatigue, mood, and quality of life in cancer survivors with cancer-related fatigue (CRF).", "results_summary": "BWL was associated with a 17% greater reduction in fatigue compared to DRL, with a small effect size (d = 0.30). Both groups showed significant improvements in mood, depressive symptoms, and quality of life over time.", "population_specificity": "Cancer survivors meeting diagnostic criteria for CRF.", "effective_dosage": "Daily 30-minute light therapy upon waking for 28 days.", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:08.117532+00:00"}
{"study_id": 64899, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The study aimed to examine the efficacy, onset time, and clinical safety of bright light therapy (BLT) as an adjunctive treatment for acute bipolar depression, not DIM.", "results_summary": "The study found that BLT was more effective than dim red light therapy (dRLT) in treating bipolar depression, with a response rate of 78.19% vs. 43.33%, and no reported hypomania or serious adverse events.", "population_specificity": "Patients with acute bipolar depression.", "effective_dosage": "Not applicable (study used light therapy, not DIM).", "study_duration": "2 weeks (1 hour every morning).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:09.284013+00:00"}
{"study_id": 64901, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the relationship between TIM-3 expression on peripheral blood mononuclear cells and disease severity in patients with immune thrombocytopenia (ITP).", "results_summary": "The study found that T-helper lymphocytes were significantly decreased in the severe bleeding group compared to mild and moderate bleeding groups, while CD56 expression was not fully detailed in the abstract.", "population_specificity": "Patients with acute ITP (n = 45) and healthy controls (n = 20).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:11.435260+00:00"}
{"study_id": 64900, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were attempting to determine the prognostic value of autograft absolute lymphocyte count (A-ALC) and autograft natural killer cells (A-NKC) for overall survival (OS) and progression-free survival (PFS) in non-Hodgkin's lymphoma (NHL) patients undergoing autologous peripheral blood hematopoietic stem cell transplantation (APBHSCT).", "results_summary": "The study found that A-ALC and A-NKC are prognostic factors for OS and PFS in NHL patients undergoing APBHSCT. No results regarding DIM were mentioned.", "population_specificity": "Non-Hodgkin's lymphoma (NHL) patients undergoing autologous peripheral blood hematopoietic stem cell transplantation (APBHSCT).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:11.920117+00:00"}
{"study_id": 64903, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the efficacy of midday bright light therapy for bipolar depression, focusing on remission rates, symptom levels, and mood polarity switches.", "results_summary": "Bright white light therapy significantly improved remission rates (68.2% vs. 22.2%) and reduced depression scores compared to placebo, with no observed mood polarity switches. Sleep quality improved in both groups without significant differences.", "population_specificity": "Adults with bipolar I or II disorder experiencing depression, on stable antimanic medication, excluding those with hypomania, mania, mixed symptoms, or rapid cycling.", "effective_dosage": "7,000-lux bright white light (intervention) vs. 50-lux dim red light (placebo).", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:14.009949+00:00"}
{"study_id": 64904, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to investigate whether bright white light therapy could reduce fatigue in multiple sclerosis (MS) patients compared to dim red light.", "results_summary": "The abstract describes the study design but does not report results, as it appears to be a protocol for a future study rather than a completed trial.", "population_specificity": "Clinically confirmed multiple sclerosis patients with a Fatigue Severity Scale (FSS) score \u226536.", "effective_dosage": "Bright white light (10,000 lux) or dim red light (<300 lux) for 1 hour twice daily.", "study_duration": "4-week treatment period.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:14.637683+00:00"}
{"study_id": 64905, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to determine whether early mood improvement after bright light treatment could predict long-term outcomes in Seasonal Affective Disorder (SAD) patients and whether BMI and atypical depression symptoms influenced treatment response.", "results_summary": "No significant prediction of treatment outcome was found based on early mood changes, but higher atypical balance scores and BMI positively predicted better treatment results.", "population_specificity": "Adult patients with Seasonal Affective Disorder (SAD), excluding those with comorbid substance abuse, suicidality, bipolar I disorder, or on antidepressant medications.", "effective_dosage": "Not mentioned", "study_duration": "Six weeks of bright light treatment (first session was controlled crossover).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:15.207658+00:00"}
{"study_id": 64906, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to investigate the interacting effects of light exposure and dopamine modulation (via phenylalanine/tyrosine depletion) on facial emotion recognition in women with subsyndromal seasonal affective disorder.", "results_summary": "In dim light, acute phenylalanine/tyrosine depletion (APTD) improved accuracy, reduced misclassification, and sped up responses to sad faces, independent of mood changes. Bright light exposure attenuated these effects, suggesting dopamine modulation influences sad emotion processing.", "population_specificity": "32 women with subsyndromal seasonal affective disorder.", "effective_dosage": "Not specified (phenylalanine/tyrosine-deficient mixture vs. balanced control mixture).", "study_duration": "Single administration per test day (two test days total).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:16.591263+00:00"}
{"study_id": 64907, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine whether dim lighting and instrumental music during urodynamic testing (UDT) could reduce patient-reported embarrassment and anxiety.", "results_summary": "Patients in the modified group (dim lighting and music) showed a greater decrease in embarrassment scores (9.72 mm) compared to the standard group (1.3 mm), though the difference was not statistically significant (p = 0.33). The study suggested a clinically meaningful improvement in patient experience despite being underpowered.", "population_specificity": "Women undergoing urodynamic testing (60 participants).", "effective_dosage": "Not applicable (intervention was environmental: dim lighting and instrumental music).", "study_duration": "Duration of the UDT procedure (not specified in the abstract).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:17.605228+00:00"}
{"study_id": 64908, "supplement_id": 1087, "safety_score": "85", "efficacy_score": 75, "quality_score": 90, "study_goal": "The researchers aimed to determine the activity and safety of combined use of BioResponse DIM\u00ae (BR-DIM) with tamoxifen in women prescribed tamoxifen for breast cancer.", "results_summary": "BR-DIM increased the 2/16\u03b1-OHE1 ratio and serum SHBG levels but reduced plasma tamoxifen metabolites, including endoxifen. No changes in breast density were observed, and adverse events were minimal and similar between treatment arms.", "population_specificity": "Women prescribed tamoxifen for breast cancer (n = 130, with 98 completing the study).", "effective_dosage": "150 mg twice daily", "study_duration": "12 months", "interactions": "Reduced plasma tamoxifen metabolites (endoxifen, 4-OH tamoxifen, and N-desmethyl-tamoxifen) were noted with BR-DIM use.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:19.426101+00:00"}
{"study_id": 64909, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effects of light treatment on circadian rhythms, sleep, and seasonal affective disorder (SAD) in personnel living in extreme Antarctic conditions.", "results_summary": "The study found little evidence of SAD or seasonal changes in melatonin duration but observed a substantial winter phase delay in melatonin rhythm, which was corrected by bright light treatment. Appropriate artificial light improved sleep timing and circadian alignment.", "population_specificity": "Personnel at the British Antarctic Survey base of Halley (75\u00b0S), living in extreme photoperiod conditions.", "effective_dosage": "Not mentioned", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:20.355881+00:00"}
{"study_id": 64910, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to identify predictors of leukemia response, relapse patterns, and resistance mechanisms (particularly CD19 downregulation and extramedullary disease) in patients with refractory/relapsed ALL treated with blinatumomab.", "results_summary": "The study found a 51% complete remission rate, with high leukemia burden, prior or active extramedullary disease predicting lower response. Extramedullary and CD19-negative disease were common at relapse, and allogeneic HCT improved survival outcomes.", "population_specificity": "65 patients with refractory/relapsed acute lymphoblastic leukemia (ALL).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:21.006442+00:00"}
{"study_id": 64911, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of IGF-1R inhibitors, including their impact on progression-free survival and overall survival in solid tumor patients.", "results_summary": "The study found no significant improvement in overall survival or progression-free survival with IGF-1R inhibitors. Some subgroups, such as those treated with dalotuzumab or with breast, colorectal, or prostate cancer, even showed harmful effects.", "population_specificity": "Patients with solid tumors", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:21.892899+00:00"}
{"study_id": 64914, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the effects of melatonin and bright light therapy versus placebo in children with chronic sleep onset insomnia and late melatonin onset.", "results_summary": "Melatonin and light therapy reduced sleep latency and advanced sleep onset, with melatonin showing stronger effects. Melatonin also advanced DLMO and improved sleep efficiency and sleep time, though it increased wake after sleep onset.", "population_specificity": "84 children (mean age 10.0 years, 61% boys) with chronic sleep onset insomnia and late melatonin onset.", "effective_dosage": "Not specified", "study_duration": "3 to 4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:24.121694+00:00"}
{"study_id": 64913, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to determine whether dim red light (sham condition) could augment the effect of antidepressant drug treatment in major depression, compared to bright white light.", "results_summary": "The study found that dim red light (sham) was less effective than bright white light in improving depression symptoms, with lower response and remission rates during the intervention period, though differences diminished after discontinuation of light therapy.", "population_specificity": "Patients with major depression (DSM-IV), including bipolar disorder, recruited from general practitioners, psychiatric practices, and open wards.", "effective_dosage": "30 minutes daily of dim red light (sham condition).", "study_duration": "5 weeks of light therapy, followed by 4 weeks of follow-up.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:25.949212+00:00"}
{"study_id": 64916, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "To determine the safety and efficacy of light therapy (LT) on excessive daytime sleepiness (EDS) associated with Parkinson disease (PD).", "results_summary": "Bright LT significantly improved EDS and sleep quality in PD patients, as measured by the Epworth Sleepiness Scale and other sleep metrics. Both bright and dim-red LT showed improvements in sleep quality, but bright LT had more pronounced effects on sleep fragmentation and daytime alertness.", "population_specificity": "31 patients with PD receiving stable dopaminergic therapy, with coexistent EDS and no cognitive impairment or primary sleep disorder.", "effective_dosage": "Bright LT or dim-red LT administered twice daily in 1-hour intervals.", "study_duration": "14 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:27.364739+00:00"}
{"study_id": 64918, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to determine whether the fraction of newly born chronic lymphocytic leukemia (CLL) cells is highest in the lymph nodes compared to other anatomical sites.", "results_summary": "The abstract does not provide results regarding DIM's effects, as the study focuses on CLL cell proliferation in lymph nodes rather than DIM.", "population_specificity": "Patients with chronic lymphocytic leukemia (CLL).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:28.837443+00:00"}
{"study_id": 64919, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to analyze evidence for circadian rhythm changes in ADHD and assess therapeutic approaches involving the circadian clock, including melatonin treatment.", "results_summary": "The study found consistent evidence linking ADHD to eveningness/later chronotype, phase delay in circadian markers, and delayed sleep onset. Melatonin treatment showed efficacy in addressing ADHD-related sleep problems, but other chronotherapeutic approaches were understudied.", "population_specificity": "ADHD patients (children and adults), totaling 4462 participants across 62 studies.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:29.418423+00:00"}
{"study_id": 64915, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to examine associations between circadian timing (including dim light melatonin onset, DLMO) and depression severity, as well as its alignment with sleep, in adults with major depressive disorder undergoing fluoxetine treatment with time in bed (TIB) restriction.", "results_summary": "For females, a phase delay after fluoxetine and TIB manipulation was associated with poorer response to fluoxetine, and depression severity was negatively correlated with phase angle difference, while males showed a positive correlation between depression severity and phase angle difference.", "population_specificity": "30 adults with major depressive disorder.", "effective_dosage": "Fluoxetine 20-40 mg daily.", "study_duration": "8 weeks (with TIB restriction for the first 2 weeks).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:29.761337+00:00"}
{"study_id": 64917, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to determine whether bright light (BL) exposure at the end of a night shift could improve driving performance compared to dim light (DL) exposure after sleep deprivation.", "results_summary": "Bright light (5600 lux) exposure reduced driving incidents and accidents compared to dim light (35 lux) after sleep deprivation, with no terminal accidents in the BL condition. BL also improved performance on the second lap of the driving circuit.", "population_specificity": "19 healthy subjects (mean age 22.8 \u00b1 4 years).", "effective_dosage": "45 minutes of bright light (5600 lux) or dim light (35 lux) exposure.", "study_duration": "Single 45-minute exposure after six hours of dim light during sleep deprivation.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:30.220574+00:00"}
{"study_id": 64920, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers sought to determine whether caffeine intake affects pupil size and amplitude of accommodation in healthy young adults.", "results_summary": "Caffeine intake significantly increased both amplitude of accommodation and pupil size compared to the vehicle, with effects observed at 30, 60, and 90 minutes post-consumption. No such increases were noted with the vehicle.", "population_specificity": "50 healthy subjects aged 19 to 25 years.", "effective_dosage": "250 mg caffeine in a single dose.", "study_duration": "Measurements taken at baseline and up to 90 minutes post-consumption.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:31.020422+00:00"}
{"study_id": 64921, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 45, "study_goal": "The researchers aimed to investigate the potential causal link between tramadol use and rebound hypoglycemia in a patient with type 1 diabetes mellitus.", "results_summary": "The study reported a case of severe rebound hypoglycemia in a type 1 diabetes patient following tramadol use, which resolved after discontinuation of the drug. The timing and specificity of the hypoglycemic episodes suggested a causal relationship with tramadol.", "population_specificity": "A 71-year-old woman with type 1 diabetes mellitus and sacroiliac joint arthritis.", "effective_dosage": "Tramadol 50 mg 3 times daily as needed.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:34.390997+00:00"}
{"study_id": 64922, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to compare the efficacy of bright light therapy (BLT) versus dim red light therapy (DIM) in treating depressive symptoms in pregnant women.", "results_summary": "The abstract does not provide results for DIM specifically, as it describes a planned study rather than completed findings.", "population_specificity": "Pregnant women (12-18 weeks pregnant) with a DSM-V diagnosis of depressive disorder.", "effective_dosage": "100 lux (dim red light therapy), daily for 30 minutes.", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:35.703991+00:00"}
{"study_id": 64923, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to determine whether Bright Light Therapy (BLT) could effectively treat depressive symptoms in Parkinson's disease patients by restoring circadian rhythm.", "results_summary": "The study compares BLT (10,000 Lux) to dim light (200 Lux) in PD patients, measuring depressive symptoms, sleep, and biological markers, but results are not yet provided in the abstract.", "population_specificity": "84 subjects with idiopathic Parkinson's disease", "effective_dosage": "30 minutes of light therapy twice daily", "study_duration": "3 months of treatment, followed by 6 months of follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:36.201247+00:00"}
{"study_id": 64924, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to summarize the biological activities and chemoprevention potential of DIM and I3C, focusing on their effects on signaling pathways and chronic disease prevention.", "results_summary": "The study found that DIM and I3C influence multiple signaling pathways related to cell division, apoptosis, and angiogenesis, supporting their role in preventing hormone-dependent cancers and potentially other chronic diseases like cardiovascular disease, obesity, and diabetes. Clinical studies indicate their broader chemoprevention potential.", "population_specificity": "Not specified (general discussion of experimental and clinical data)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:37.776621+00:00"}
{"study_id": 64925, "supplement_id": 1087, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether a sleep and circadian-based treatment (scheduled evening sleep and enhanced lighting) could improve circadian adaptation, alertness, performance, and sleep in older adults during night shifts.", "results_summary": "The treatment improved alertness and sustained attention on nights 2 and 3, maintained sleep duration similar to baseline, and advanced circadian timing, while the control group showed no improvement in these measures.", "population_specificity": "18 older adults (mean age 57.2\u00b13.8 years) in a simulated shift work protocol.", "effective_dosage": "Not specified (non-pharmacological intervention).", "study_duration": "4 day shifts followed by 3 night shifts.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:41:38.598449+00:00"}
